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PREFACE
Chapters 2 - 6 have been written as separate manuscripts for publication. There
may be some repetition of presented material between chapters. Chapter 4 has been
published and chapters 2 and 5 are in review.
v
TABLE OF CONTENTS
DEDICATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ii
ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . iii
PREFACE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . x
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xi
LIST OF APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . xii
LIST OF ABBREVIATIONS . . . . . . . . . . . . . . . . . . . . . . . . . xiii
ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv
CHAPTER
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 Powered Push-off at the Prosthetic Ankle Joint . . . . . . . . 2
1.1.1 Metabolic Effort . . . . . . . . . . . . . . . . . . . . 2
1.1.2 Gait Symmetry . . . . . . . . . . . . . . . . . . . . 4
1.1.3 Evaluating the Prosthetic Use in Daily Life . . . . . 6
1.1.4 Fall Risk . . . . . . . . . . . . . . . . . . . . . . . . 9
1.2 Overview of Dissertation . . . . . . . . . . . . . . . . . . . . . 11
2. The Effect of Powered Ankle Prostheses on Muscle Activity
During Walking . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.2.1 Participants . . . . . . . . . . . . . . . . . . . . . . 16
2.2.2 Experimental Protocol . . . . . . . . . . . . . . . . 17
2.2.3 Data Analyses . . . . . . . . . . . . . . . . . . . . . 18
vi
2.2.4 Statistical Analyses . . . . . . . . . . . . . . . . . . 20
2.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.3.1 iEMG Across the Gait Cycle . . . . . . . . . . . . . 20
2.3.2 Muscle Activity during Early Stance . . . . . . . . . 21
2.3.3 Muscle Activity during Late Stance . . . . . . . . . 21
2.3.4 Muscle Activity during Swing . . . . . . . . . . . . 25
2.3.5 Correlations between Muscle Activity and Metabolic
Cost . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.4.1 Limitations . . . . . . . . . . . . . . . . . . . . . . . 30
2.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3. Determine If the Addition of Prosthetic Ankle Power Delays
the Onset of Muscular Fatigue During an Extended Bout of
Walking . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.2.1 Participants . . . . . . . . . . . . . . . . . . . . . . 34
3.2.2 Protocol . . . . . . . . . . . . . . . . . . . . . . . . 36
3.2.3 Data Analysis . . . . . . . . . . . . . . . . . . . . . 37
3.2.4 Statistical Analysis . . . . . . . . . . . . . . . . . . 37
3.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.3.1 Walking Duration and Perceived Exertion . . . . . . 39
3.3.2 Spatiotemporal Parameters . . . . . . . . . . . . . . 40
3.3.3 Ground Reaction Forces (GRF) . . . . . . . . . . . 41
3.3.4 Joint Mechanics . . . . . . . . . . . . . . . . . . . . 43
3.3.5 Joint Range of Motion (ROM) . . . . . . . . . . . . 45
3.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.4.1 Walking Endurance and Perceived Exertion . . . . . 48
3.4.2 Compensatory Mechanisms to Fatigue . . . . . . . . 48
3.4.3 Propulsive GRF . . . . . . . . . . . . . . . . . . . . 51
3.4.4 Ability to Provide Stance Stability . . . . . . . . . . 52
3.4.5 Limitations . . . . . . . . . . . . . . . . . . . . . . . 52
3.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4. Wearable Sensors Quantify Mobility in People with Lower
Limb Amputation During Daily Life . . . . . . . . . . . . . . . 55
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
4.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
4.2.1 Subjects . . . . . . . . . . . . . . . . . . . . . . . . 59
4.2.2 Experimental Protocol . . . . . . . . . . . . . . . . 60
4.2.3 Data Analysis . . . . . . . . . . . . . . . . . . . . . 60
4.2.4 Statistical Analysis . . . . . . . . . . . . . . . . . . 63
vii
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
4.3.1 Cadence . . . . . . . . . . . . . . . . . . . . . . . . 66
4.3.2 Walking Speed . . . . . . . . . . . . . . . . . . . . . 67
4.3.3 Walking Speed vs. Stride Length . . . . . . . . . . . 68
4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
4.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
5. The Influence of Powered Prostheses on User Perspectives,
Metabolics, and Activity: A Randomized Crossover Trial . . 77
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
5.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
5.2.1 Participant Recruitment . . . . . . . . . . . . . . . 80
5.2.2 Experimental Protocol . . . . . . . . . . . . . . . . 80
5.2.3 Data Analysis . . . . . . . . . . . . . . . . . . . . . 82
5.2.4 Statistical Analysis . . . . . . . . . . . . . . . . . . 84
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
5.3.1 Participant Details . . . . . . . . . . . . . . . . . . 85
5.3.2 Metabolic Cost . . . . . . . . . . . . . . . . . . . . 85
5.3.3 Activity Data . . . . . . . . . . . . . . . . . . . . . 88
5.3.4 Questionnaires . . . . . . . . . . . . . . . . . . . . . 90
5.3.5 User Feedback . . . . . . . . . . . . . . . . . . . . . 90
5.3.6 Correlations . . . . . . . . . . . . . . . . . . . . . . 92
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
5.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
6. Quantifying the Effect of Powered Prostheses on Toe Clear-
ance Using Inertial Measurements . . . . . . . . . . . . . . . . . 101
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
6.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
6.2.1 Participants . . . . . . . . . . . . . . . . . . . . . . 104
6.2.2 Experimental Protocol . . . . . . . . . . . . . . . . 105
6.2.3 Data Processing and Analysis . . . . . . . . . . . . 106
6.2.4 Statistical Analysis . . . . . . . . . . . . . . . . . . 110
6.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
6.3.1 Feasibility Study . . . . . . . . . . . . . . . . . . . . 111
6.3.2 Prosthetic Comparison Study . . . . . . . . . . . . 113
6.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
6.4.1 Evaluating Fall Risk in Daily Life . . . . . . . . . . 114
6.4.2 Feasibility of the Center of Rotation Assumption . . 114
6.4.3 Prosthetic Comparison in Daily Life . . . . . . . . . 116
6.4.4 Limitations . . . . . . . . . . . . . . . . . . . . . . . 118
6.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
viii
7. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
7.1 Summary and Recommendations for Future Work . . . . . . 119
7.2 Long-term Vision . . . . . . . . . . . . . . . . . . . . . . . . . 122
APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124




2.1 Normalized EMG linear envelopes over the gait cycle . . . . . . . . 22
2.2 Integrated EMG (iEMG) over the entire gait cycle . . . . . . . . . 23
2.3 Integrated EMG (iEMG) in distinct phases of gait . . . . . . . . . 24
2.4 Co-contractions and their relationships with metabolic cost . . . . 26
2.5 Relationships between metabolic cost and muscle activity . . . . . 27
3.1 Relevant phases of the gait cycle for joint power . . . . . . . . . . . 38
3.2 Walking endurance and perceived exertion . . . . . . . . . . . . . . 40
3.3 Spatiotemporal parameters before and after fatigue . . . . . . . . . 41
3.4 Ground reaction forces (GRF) before and after fatigue . . . . . . . 42
3.5 Sagittal joint mechanics for the hip, knee, and ankle joints . . . . . 44
3.6 Joint mechanics symmetry during specific phases of the gait cycle . 46
3.7 Sagittal angles for the hip, knee, and ankle joints . . . . . . . . . . 50
4.1 Sensor setup and processing . . . . . . . . . . . . . . . . . . . . . . 59
4.2 Flowchart: syncing steps with location data . . . . . . . . . . . . . 63
4.3 Flowchart: valid walking stride criteria . . . . . . . . . . . . . . . . 64
4.4 Cadence in daily life . . . . . . . . . . . . . . . . . . . . . . . . . . 65
4.5 Walking speed in daily life . . . . . . . . . . . . . . . . . . . . . . . 69
5.1 Consort flow diagram for recruitment, enrollment, and analysis . . 86
5.2 Overall step count and step count away from home . . . . . . . . . 88
5.3 Walking speed in-lab and in daily life . . . . . . . . . . . . . . . . . 89
5.4 Prosthetic comparisons in questionnaires and surveys . . . . . . . . 91
5.5 Relationships between prosthetic preference and other outcomes . . 93
5.6 Relationships between step counts and other outcomes . . . . . . . 94
6.1 Placement of inertial measurement unit (IMU) and reflective markers. 106
6.2 Flowchart: algorithm schematics . . . . . . . . . . . . . . . . . . . 108
6.3 Sensor’s rotation about the stationary center of rotation (CoR) . . . 108
6.4 Toe clearance estimates from the feasibility study . . . . . . . . . . 112
6.5 Toe clearance and its variability in daily life . . . . . . . . . . . . . 113




3.1 Participant demographics . . . . . . . . . . . . . . . . . . . . . . . . 35
3.2 Joint range of motion (ROM) and symmetry indices (SI) . . . . . . 47
4.1 Participant demographics and data quantity . . . . . . . . . . . . . 57
4.2 Group comparisons of activity during daily life . . . . . . . . . . . . 66
4.3 Comparison of activity taken in and away from home . . . . . . . . 67
5.1 Participant demographics . . . . . . . . . . . . . . . . . . . . . . . . 87
5.2 Step count and walking speed in-lab and in daily life (mean ± SD) 87
5.3 User feedback and changes in capacity and performance . . . . . . 96
6.1 Mean absolute differences between methods, mean ± sd in cm . . . 111
6.2 Comparisons of toe clearance and its variability between prostheses 114
A.1 Spatiotemporal parameters (pairwise p value and Hedge’s g) . . . . 126
A.2 Ground reaction force peaks (pairwise p value and Hedge’s g) . . . 126
A.3 Joint power peaks (pairwise p value and Hedge’s g) . . . . . . . . . 127
A.4 Joint ranges of motion (pairwise p value and Hedge’s g) . . . . . . . 128
A.5 Peak joint angle, moment, and power at the hip, knee, and ankle . 129
A.6 Symmetry indices for joint angle, moment, and power . . . . . . . . 130
B.1 Accelerometer (ACC) sensor data collection month and quantity . 132
B.2 IMU sensor data collection month and quantity . . . . . . . . . . . 132




A. Appendix for Chapter 3 . . . . . . . . . . . . . . . . . . . . . . . . . 125




SACH Solid ankle cushion heel
ESAR Energy storage and return
DR Dynamic response
TTA Transtibial amputation
COM Center of mass
GRF Ground reaction force
ICF International Classification of Functioning, Disability, and Health
GPS Global positioning system
IMU Inertial measurement unit
MTC Minimum toe clearance













MVC Maximum voluntary isometric contraction
COT Cost of transport
iEMG Integrated EMG
CCI Co-contraction index
ROM Range of motion







ZUPT Zero velocity updates
CON Control
MCID Minimal clinically important difference
MDC Minimal detectable change
PEQ Prosthetic Evaluation Questionnaire
SF-36 Short Form 36 general health questionnaire
VAS Visual analog scale
RFC Relative foot clearance
CoR Center of rotation
xiv
ABSTRACT
Powered ankle prostheses aim to replicate the biological ankle function for indi-
viduals with transtibial amputation. The effects of powered prostheses on gait have
been experimentally quantified in several studies. The findings are non-universal
and potentially dependent on user characteristics. Disparate responses to the pow-
ered prosthesis among users point to unanswered questions regarding the fundamental
biomechanical effects of the device. Additionally, it is unknown how powered prosthe-
ses impact daily function. To address these gaps in knowledge, I investigated various
biomechanical and clinical outcomes of the powered prosthesis in the laboratory and
in the users’ everyday lives. My research can be broken down into two approaches:
experimental analyses of functional capacity and examinations of functional perfor-
mance in everyday life.
To assess functional capacity in the lab, I first explored users’ neuromuscular adap-
tations to the powered prosthesis (Chapter 2). Specifically, I quantified changes in
lower-limb muscle activations and their relationships with changes in metabolic cost.
This aim revealed the potential importance of effective residual limb stabilization as
a contributor to metabolic reductions. Second, I sought to quantify fatigue-related
compensations in walking with the powered prosthesis (Chapter 3). While the pow-
ered prosthesis did not improve the user’s endurance, there were differences in hip
joint compensation strategies when wearing unpowered and powered prostheses.
I then developed methods to bring gait analysis out of the lab, to assess functional
performance in daily life. I first explored the use of portable GPS and IMU sensors
to quantify functional mobility in everyday walking (Chapter 4). Through this work
xv
I demonstrated the clinical viability of estimating cadence and walking speeds in
different real-world environments. I then applied these techniques to assess changes
to the volume and characteristics of walking with a powered prosthesis in daily life
(Chapter 5). Further, I examined the relationships between capacity in the lab,
performance in daily life, and the users’ perceptions of mobility. Lastly, I examined
potential implications of the powered prosthesis on trips and falls in daily life (Chapter
6). In this study, I applied a novel method for using IMU signals to estimate minimum
toe clearance in daily life. Findings from Chapters 5 and 6 suggest there were no
universal powered prosthesis-related changes to gait in daily life.
Together, these works add to the existing body of literature and reinforces the
notion that the benefits of the powered prosthesis are non-universal and subject-
specific. Chapters 4 through 6 specifically represent a meaningful first step toward





Lower-limb amputation (LLA) is a prevalent and ever-growing issue in the United
States today. In 2005, close to 1 million people in the United States were living
with LLA and this figure is projected to more than double by 2050 [163]. People
with LLA are able to regain some level of functional mobility using a prosthesis. In
the United States, prostheses are prescribed by first assessing a patients’ functional
mobility using the Medicare Functional Classification Levels, or K-levels [41]. Based
on this designation, they are prescribed devices with appropriate functionalities.
Most commercially available, prosthetic feet are unpowered devices. Solid ankle
cushion heel (SACH) feet, which comprise of a soft material molded over a rigid keel,
provide little energy storage and return but offer greater stability. Energy storage and
return (ESAR), also referred to as dynamic response (DR), feet consist of a carbon
fiber spring that stores energy during loading response and releases this energy return
during push-off. By nature, unpowered devices cannot perform positive net work and
produce less than one eighth of the power compared to the biological plantarflexor
muscles [11, 164]. Due, in part, to these deficiencies, individuals with transtibial
amputation (TTA) walk with increased metabolic effort [27, 48, 155], increased muscle
activation [74, 158], decreased symmetry and stability [133, 5, 46, 72, 74, 81], and at
a slower walking speed compared to people without amputation [155, 11]. Individuals
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with TTA also tend to rely more on their intact limb and are correspondingly at a
greater risk for developing osteoarthritis in the intact side knee and hip [141, 93].
These functional deficits represent barriers to healthy amounts of physical activity
[19] and contribute to a lower quality of life and greater risk for developing secondary
health conditions such as obesity and hypertension [116, 146].
1.1 Powered Push-off at the Prosthetic Ankle Joint
Recent prosthetic research has focused on replicating the biological ankle plan-
tarflexor function by generating power during push-off [6, 24, 21, 66, 58] in hopes of
restoring a normal gait pattern. Several powered ankle prostheses have been devel-
oped which successfully provide active torque at the ankle comparable to that of the
biological ankle during push-off and allow for increased range of motion of the ankle
[66, 6, 63, 21]. To date, however, the BiOM (now Empower, Ottobock, Duderstadt,
Germany) is the only device that is commercially available.
To evaluate the effectiveness of the powered prosthesis, research efforts have ex-
amined several factors that influence functional mobility, including metabolic effort,
work done on the body center-of-mass (COM), inter-limb symmetry, stability and fall
risk, and self-selected walking speed. I will describe the efforts in each of these areas
in the following sections.
1.1.1 Metabolic Effort
Individuals with TTA use greater metabolic effort when walking, compared to
people without amputation [26, 155]. Elevated metabolic costs can be attributed to
neuromuscular strategies to compensate for the lack of biological plantarflexors and
adversely affect functional mobility. The powered prosthesis aims to replicate part of
the biological push-off torque, lessen compensations at other joints, and theoretically
reduce metabolic costs. Thus, one way to evaluate the efficacy of a powered push-off
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is to measure metabolic normalization, or how much the prosthesis was able to reduce
metabolic effort in users to that of non-amputees [94, 63, 130, 120, 49].
Several studies found that metabolic costs decreased with powered push-off during
level walking [7, 63, 94, 130]. However, in cohorts with wider age ranges, metabolic
benefits were not observed [49, 102]. This may indicate that the ability to uti-
lize power to reduce metabolic effort depends on individual characteristics. Specifi-
cally, Gardinier et al. found a strong association between the participants K-levels
and metabolic effort such that more active, higher functioning individuals reduced
metabolic costs, while lower functioning individuals increased metabolic costs with
the powered prosthesis. It is possible that the benefits of this power may only apply
when more power is needed, such as walking at faster speeds [63] or uphill [102].
Overall, the device may be limited due to its uni-articular nature whereas some of
the biological ankle plantar flexor muscles are biarticular across the ankle and knee
joints. The lack of metabolic benefits may also be due to the loss of mechanical energy
transferred from the residual limb to the prosthetic end effector via the limb-socket
interface.
During gait, muscle activations are ultimately the primary drivers of metabolic
cost [79]. As such, the widely varied metabolic response to the powered push-off may
also relate to the participants’ neuromuscular control strategy. In general, individ-
uals with TTA walk with increased magnitude and duration of muscle activation at
the residual limb quadriceps [158, 144, 118, 124], and gluteus maximus [158, 144],
compared to individuals without amputation.
Neuromuscular control strategies are sensitive to the prosthetic device used. Ven-
tura et. al found that with prosthetic ESAR feet, individuals with TTA walked with
reduced activity at the residual limb hamstrings but with increased activity at the
vastus and rectus femoris muscles [153]. Another study found that as the stiffness
of the ESAR decreased, individuals with TTA walked with increased activity at the
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bilateral vastus muscles and the residual limb gluteus medius [39]. In both studies,
the neuromuscular response to different prosthetic characteristics were highly variable
across subjects.
The effects of powered prostheses on muscle activity are not clear. Only one
previous study has quantified changes in muscle activity with varying levels of push-
off power generation [120]. Using an experimental prosthetic emulator, the authors
found that with increasing prosthesis work, activity in the residual limb during push-
off increased, while activity in the intact limb during early stance decreased. However,
it is unclear if these findings will persist when walking with a commercially available
powered prosthesis, which is significantly heavier due to the onboard battery and
electronics. Additionally, prior work did not measure muscle co-contraction. This
is important as co-contraction of agonist and antagonist muscles about a joint is
another source of metabolic cost. Individuals with TTA co-contract their residual
limb knee muscles to stabilize the residual limb-socket interface during gait [137].
As increased energy storage and return in unpowered prostheses has been shown to
require increased stability [39, 153], a powered push-off may similarly yield undesirable
increases to residual limb knee co-contraction.
1.1.2 Gait Symmetry
A symmetric gait pattern is a characteristic of unimpaired gait [8, 73]. For peo-
ple with amputation, a complete symmetry may not always be desired due to the
prosthetic limb being inherently different to the intact limb. However, this may have
long-term health consequences such as osteoarthritis, as asymmetry in loading is asso-
ciated with increased risk of knee osteoarthritis in the intact limb [18]. Osteoarthritis
and knee pain at the intact limb are prevalent in the TTA population and represent
significant barriers to healthy amounts of physical activity [18, 106, 104]. Reducing
the overloading on the intact limb, and thereby increasing kinetic symmetry, may
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mitigate the increased risk of people with TTA developing osteoarthritis in the intact
limb [93]. Specifically, increased peak knee external adduction moment is associated
with the development of knee osteoarthritis [9, 42]. Prosthetic ankles that produce
greater power peaks during push-off have been found to reduce the peak knee external
adduction moment at the intact side knee [105]. Thus, powered prostheses could be
expected to reduce intact limb knee adduction moments. However, changes to intact
limb loading with the powered prosthesis were speed dependent. While the powered
prosthesis reduced intact limb GRFs at slow to moderate speeds (0.75 - 1.5 m/s),
it reduced adduction moments at the intact side knee only at faster speeds (1.5 and
1.75 m/s) [56].
While we may expect that restoring symmetry to the ankle power may alleviate
the overreliance on the intact limb, the effects of the powered prosthesis on gait sym-
metry remains unclear. The powered prosthesis reduced stance and swing duration
asymmetries, which may indicate a decrease in overreliance on the intact limb [38].
However, walking with the powered prosthesis did not reduce interlimb asymmetries
of peak knee power absorption. As with metabolic effort, it is possible the benefits of
powered prostheses on gait symmetry may only be present when more ankle power is
needed. Walking on a loose rock surface is one such activity that may require greater
added power but did not affect asymmetries [50]. Walking on an uphill slope, sym-
metry increased with the powered prosthesis when walking on steep inclines of 6 and
9 degrees [102]. Overall, the effects of powered prostheses on kinetic gait symmetry
may be limited by the uni-articular nature of the prosthesis, which lead to compen-
satory mechanisms in the proximal joints [38]. However, walking tasks that require
more push-off torque may yield adaptations to gait symmetry.
Gait symmetry may also change throughout prolonged activity as people adapt to
factors such as pain or muscle fatigue. During longer walks, individuals with TTA may
experience muscular fatigue and require more push-off power at the prosthetic ankle.
5
Previous studies primarily assessed gait symmetry during short periods of walking.
Therefore, it is unknown if gait symmetry changes over prolonged walking. The
effects of lower-limb fatigue on unpowered prosthesis users has only been explored in
one study to date [160]. Yeung et al. examined changes to six participants with TTA
before, between, and after two 30-minute bouts of continuous treadmill walking and
found decreased power absorption and generation in the intact limb ankle, decreased
peak propulsion ground reaction force, and increased power generation at the intact
limb hip joint. However, authors did not record muscle activity or perceived exertion.
Therefore, further work is needed to characterize the effects of fatigue when walking
with a powered prosthetic foot.
1.1.3 Evaluating the Prosthetic Use in Daily Life
While instrumented gait analysis has been the standard for evaluating prosthetic
interventions by measuring an individual’s capacity within a controlled setting, it
offers little insight on the potential changes to functional mobility in the everyday,
real-world setting [124]. According to the International Classification of Functioning,
Disability and Health (ICF), evaluating performance, i.e., what one does in their ac-
tual environment is also an important component of characterizing functionality [114].
To this end, an increasing number of studies have utilized portable accelerometry-
based sensors to quantify physical activity in daily life. The step count is an informa-
tive, robust indicator of overall health and amount of physical activity and has been
commonly measured in daily life to characterize individuals with [88, 140, 115, 68, 138]
and without lower limb amputation [150, 151, 113, 43]. Activity levels describe the
intensity of physical activity in daily life, and are typically reported as durations
of light, moderate, or hard activity in a day, based on the vector magnitude of the
accelerometer signal [44, 140, 1]. However, the large between-subject variability in
daily step counts and activity levels may indicate its limited sensitivity as an outcome
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measure to evaluate prosthetic interventions.
The ability to vary cadence is one of the criteria for higher functioning levels of
mobility as set by the Medicare K-level guidelines [41]. A recent study has explored
the viability of quantifying cadence variability in daily life [3, 4]. In this study, ca-
dence was estimated as the step count per minute epoch, and cadence variability was
estimated using the distribution of cadence values over 7 days. However, commercial
activity monitors will underestimate cadence if walking is not continuous for the entire
minute epoch [29], and simple accelerometer-based activity monitors have decreased
accuracy at slower walking speeds [43]. These issues may be particularly problem-
atic for individuals with TTA as they tend to walk slowly and in short bouts [88].
Therefore, more advanced signal processing techniques may be required to measure
cadence on a stride-by-stride basis.
Walking speed has long been established as a robust indicator of functional mo-
bility. Previous works have used walking speed as an outcome measure to assess
mobility [5, 45, 64] and classify individuals’ ability for community ambulation [117].
Assessed in the laboratory, the effect of a powered push-off on preferred walking speed
is unclear. Younger individuals with TTA increased their preferred walking speed on
flat [38] and uneven rock surfaces [50]. With a more diverse cohort, some participants
increased their preferred walking speed with a powered push-off [63], while some par-
ticipants did not [49, 102]. This discrepancy in the findings may be attributed to
different methods of measuring preferred walking speed. While Herr et al. [63] incre-
mentally increased and decreased treadmill belt speeds until the participant indicated
they were walking at a preferred walking speed, other studies [38, 49, 102] had partic-
ipants walking over ground at a self-selected speed. No previous study has measured
walking speed as performed in daily life.
Another important component of mobility is community-level engagement [41].
Because there is no measurable standard for how well one engages in the commu-
7
nity, clinicians typically subjectively assess community engagement through patient
self-reports [80]. The emergence and prevalence of global positioning system (GPS)
technology in smartphones in the past decade has opened avenues for researchers to
explore the feasibility of quantifying community-level ambulation using GPS data in
daily life [127, 156, 84, 75, 68, 69]. Community engagement is typically described
as the number of steps taken in the community or frequency of visits to community
environments. However, this approach may only provide indirect insight into how
well people move within community environments. Quantifying mobility using walk-
ing speed or cadence variability in different locations and environments may provide
more insight into one’s ability for community ambulation.
While in-clinic tests such as the 10-meter walk test are capable of measuring
steady-state walking speed [45], this may not represent comfortable walking speed
in daily life [115]. Recent developments of inertial measurement units (IMU) and
inertial navigation algorithms have made it possible to accurately calculate stride-
by-stride spatiotemporal gait parameters, by mounting the IMU sensor to the foot.
This approach, referred to as “pedestrian dead-reckoning,” estimates the position
of the foot-mounted sensor by integrating the acceleration signal twice [110]. The
gyroscope signal from the IMU is used to detect periods of low movement during
foot-flat, assuming no slip between the foot and the ground. In these low-movement
foot-flat periods, zero velocity updates are applied to correct for integration error and
acceleration signal drift. Though this approach has not yet been applied to the LLA
population, experiments successfully calculated travel distance with an error of 1%.
With some modifications to stride segmentation, the approach could be applied to
calculate stride-by-stride measures of walking speed in daily life. Examining walking
speeds in daily life could provide insight on everyday performance with a powered
prosthesis, to supplement measures of walking speed capacity as presented in previous
studies [63, 38, 50, 49, 102].
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1.1.4 Fall Risk
Mitigating fall risk is an important consideration for prosthetic interventions, es-
pecially for individuals with TTA, as they are more susceptible to tripping [90, 98].
Surveys regarding fall occurrence showed that more than 50% of individuals with
lower-limb amputations had experienced falls in the past year [90, 98]. Falls have
been reported to affect the individual’s confidence in walking and fear of falling. In
addition to the resulting potential physical injuries, fear of falling may affect func-
tional mobility and physical activity in daily life [98]. Individuals with TTA are
particularly susceptible to trips due to the inability of the prosthetic foot to actively
dorsiflex during swing. This contributes to a low minimum toe clearance (MTC),
or the vertical distance between the lowest point of the foot and the ground at the
minimum point of swing. Insufficient MTC can lead to trips and subsequently falls
[103, 51, 31]. Previous works have found associations between increased fall risk and
low MTC and high stride-to-stride MTC variability in healthy non-amputees [99, 136]
and people with TTA [78, 128].
The MTC may be affected by the type of prosthesis used. For example, the
Proprio Foot (Ossur, Reykjavik, Iceland) is a microprocessor prosthesis, which is
the only device to provide active dorsiflexion during swing. Using this foot, people
with TTA had increased MTC [129]. While the BiOM powered prosthesis does not
actively dorsiflex the foot, it may help initiate swing as it produce comparable step-
to-step transition work at the trailing prosthetic limb to that of the intact limb [130].
On a loose rock surface, the BiOM powered prosthesis increased MTC relative to
that of the unpowered prosthesis but was still lower than that of the intact limb
[50]. Additionally, the differences between powered and unpowered prostheses were
small, the powered prosthesis was in a more plantarflexed position, and there were
no kinematic differences at the hip or knee joints between prostheses. Thus, authors
attributed the increase in MTC to the small changes in intact limb knee flexion during
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stance.
To better understand the role of MTC in fall risk, it is important to determine how
it changes in daily life, when surfaces are varied and speed is modulated. Laboratory
findings may also be limited by the size of the motion capture area and the number
of walking surfaces that can be simulated in the laboratory. MTC has been found
to be sensitive to the walking surface in individuals with [51] and without TTA
[135]. Thus, it is important to examine the effects of prosthetic interventions on
a variety of real-world environments. Further, measuring MTC variability in walks
over straight, level-ground walkways or treadmills may provide useful information on
internal sources of movement variability, but limited information on external sources
for variability. In contrast individuals experience many external sources for MTC
variability in daily life (e.g., turning, changing speed, obstacle navigation, traversing
slopes). Measuring MTC variability from a distribution of MTC values derived from
everyday walking may provide additional information on the real-world effects of the
powered prosthesis on fall risk.
Measuring MTC in daily life is now possible with wearable sensors and can pro-
vide a large sample size and describe external, real-world sources for between-stride
variability (e.g., turning, changing speed, obstacle navigation, traversing slopes). Sev-
eral previous studies have explored different methods of measuring MTC using a foot
mounted IMU set-up. The aforementioned “pedestrian dead-reckoning” algorithm to
foot mounted inertial measurements yields a reliable stride-by-stride estimate of the
IMU’s position trajectory during walking [110]. Some studies have used the position
trajectory to calculate a relative measure of foot clearance, by subtracting the verti-
cal distance between the foot at the lowest point of swing and the foot at foot-flat
[12, 87]. However, this approach is not sensitive to the foot’s sagittal angle during
swing. A more plantarflexed foot during swing would physically reduce the MTC,
but the relative foot clearance measure would not be able to detect this variability.
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To address this issue, the toe (the point on the foot that is lowest during swing)
could be located relative to the IMU. While manually measuring the toe’s location
relative to the IMU is a potential solution, it would likely lead to precision issues, as
sensor placement could be varied by the user during the collection period. The sensor
location relative to the toe and heel can also be calculated at every stride [95, 28].
However, this approach requires prior knowledge of the shoe size and the assumption
that the heel and toe are at a vertical displacement of 0 at heel strike and toe-off, re-
spectively. These assumptions may not hold true on slopes or uneven surfaces, which
are common in real-world walking surfaces. Therefore, quantifying MTC in daily life
is an area of research that warrants further improvement.
1.2 Overview of Dissertation
The benefits of powered push-off are not universal nor conclusive. To provide con-
text to the changes to metabolic cost of walking (or lack thereof), examining muscle
activation patterns may be a direct approach to explaining the wide variability of
metabolic responses between users. Due to previous studies examining short bouts
(< 8 minutes) of walking, it is also unclear if the powered push-off’s effects on gait
symmetry persist over longer walking durations. Further, all previous studies have
characterized the capacity for mobility with powered prostheses in controlled labora-
tory settings. To address these gaps, I quantified the effects of the powered push-off
in the laboratory setting using conventional experimental paradigms and in daily life
using novel approaches.
The first aim (Chapter 2) was to quantify the effects of powered prostheses on
muscle activity during walking. In this work, I used surface electromyography to
measure muscle activation and co-contraction in individuals with TTA, and how they
related to the metabolic cost of walking. I tested the hypotheses that the powered
push-off would alter muscle activity patterns and that changes in muscle activity
11
would be positively related to changes in metabolic cost. This work provided insight
into the potential muscular compensations to walking with a heavier prosthesis and
identified muscle groups to strengthen to effectively walk with the powered push-off.
The second aim (Chapter 3) was to experimentally quantify the biomechanical
effects of powered prostheses on a fatiguing bout of walking. Participants walked
with unpowered and powered prostheses, in random order, for as long as possible at
a fast speed. I measured participants’ endurance with each prosthesis and made pre-
/post-fatigue comparisons of joint kinematics and kinetics, ground reaction forces, and
muscle activity. This work revealed shortcomings of commercially available powered
prosthetic ankles for long-duration walking.
The third aim (Chapter 4) explored the clinical viability of using wearable sen-
sors to quantify functional mobility in daily life. I used accelerometer data from
prosthetic foot-mounted portable activity monitors to calculate stride-by-stride mea-
sures of cadence, walking speed, and stride length for everyday walking strides over
two weeks of unconstrained activity. GPS data from participants’ phones were also
used to provide location context to walking data. This work demonstrated that pedes-
trian dead-reckoning algorithms can be used to quantify walking characteristics in the
unconstrained, free-living environment.
The fourth aim (Chapter 5) used the methodologies established in Chapter 4
to determine the effects of powered prostheses on everyday walking. Further, I cross-
examined changes in everyday walking quantity (step count) and ability (walking
speed) to in-lab measures of metabolic cost and user-reported perception of mobility.
This work highlighted the need for prosthetic evaluation to consider both perception
and objective measures to better inform prosthetic prescription.
The fifth aim (Chapter 6) quantified minimum toe clearance and its between-
stride variability for unpowered and powered prostheses in daily life. As part of this
aim, I explored a novel method of measuring minimum toe clearance in daily life using
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inertial measurement units (IMU). With the assumption that the foot mounted IMU
rotates about the toe with a constant moment arm during late stance, I approximated
the location of the toe using the IMU signals to estimate minimum toe clearance. This
aim explored the implications of a powered prosthesis on fall risk in daily life.
In Chapter 7, I discuss the overall findings from the multifaceted approaches
described above. I also reflect upon limitations in the work and make several sugges-
tions for future studies. This dissertation makes four unique contributions to the field.
First, it explores relationships between activations and co-contractions of lower-limb
muscles and metabolic cost of walking. Second, it examines the limiting factors to
long-duration walks and how the powered prosthesis alters the effects of fatigue on
lower-limb joint mechanics. Third, this dissertation evaluates the powered prosthe-
sis by exploring the interconnected relationships between user perception, functional
capacity, and everyday performance. Lastly, this work examines a novel approach to
quantifying MTC in daily life. By assessing a variety of factors that constitute func-
tional mobility, these contributions can inform future decisions made by researchers




The Effect of Powered Ankle Prostheses on Muscle
Activity During Walking
2.1 Introduction
Lower limb prostheses enable individuals with transtibial amputation (TTA) to
ambulate independently in daily life. However, current prostheses do not completely
replace the function of the biological ankle plantarflexors, which are responsible for
support, propulsion, and swing initiation [108]. As a result, people with TTA adopt
compensatory strategies characterized by kinematic and kinetic asymmetries [11].
These strategies are associated with increased metabolic energy [70, 145] and al-
tered muscle activity during walking. Specifically, individuals with TTA have greater
muscle activity in the residual limb quadriceps [158] and hamstrings [158, 74] and
increased co-contraction of residual limb ankle and knee muscles [137] compared to
their intact limb or limbs of non-amputees.
To better replicate the function of the intact ankle, researchers have developed
motorized ankle prostheses. One such device, the BiOM (now EmPower, Ottobock,
Duderstadt, Germany) uses a reflexive controller to provide active torque at the ankle
during push-off and increased ankle range of motion [7, 63]. Outcomes with this device
have been mixed. In some studies, people preferred to walk faster when wearing the
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powered ankle compared to unpowered devices [38, 63], while in others there were no
differences [49]. Additionally, some studies found that participants used significantly
less metabolic energy when walking with powered ankle prostheses [63, 130] while
others found no differences [49, 102].
There are several possible explanations for the discrepancies in prior research.
First, the current version of the powered ankle prosthesis does not cross the knee
and thus acts more like a soleus muscle than the biarticular gastrocnemius muscle.
This may limit the transfer of energy from the foot to the body center of mass
(COM) during gait. In fact, recent research demonstrated that while the powered
prosthesis increased the net work at the prosthetic ankle, it did not increase the
individual leg step-to-step transition work when walking on a range of slopes [102].
Another potential explanation is that the prosthesis was not tuned effectively for each
participant. For example, the amount of work done by the prosthesis on each stride
is currently scaled to match normative data for intact ankle work. Given the losses
through interaction with the socket and loss of power transfered across the knee, it
is possible that users require more work on the prosthetic side to normalize gait. A
recent study found that people used less metabolic energy when the prosthetic ankle
produced work that was greater than that of an intact limb [71]. However, even with
higher levels of ankle work, metabolic costs may still not be different to costs incurred
with an unpowered prosthesis [120].
Another possible explanation for the lack of benefit of powered prostheses is that
users may not have been able to adapt their neuromuscular control strategy appro-
priately to utilize the added power. Prior research suggests that individuals with
TTA have some ability to alter their neuromuscular control in response to different
prostheses. Ventura et al. found that people with TTA reduced activation of the
muscles contributing to propulsion and increased activation in muscles contributing
to body support when walking with a passive prosthesis modified to supply greater
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energy return [153]. The need for increased stability could lead to an increase in
co-contraction, potentially incurring additional metabolic costs. In another study,
using an experimental prosthetic emulator, Quesada et al. found that with increasing
prosthesis work, activity in the residual limb during push-off increased, while activity
in the intact limb during early stance decreased [120]. However, neither study specif-
ically explored the relationship between changes in muscle activity or co-contraction
and metabolic costs.
The purpose of this study was to determine if people with TTA alter muscle
activity when using a commercially available powered ankle prosthesis, relative to an
unpowered prosthesis. We also compared these data to that of healthy individuals
without amputation to assess if the powered prosthesis normalized muscle activity.
A secondary goal was to explore the relationship between changes in muscle activity
and changes in metabolic cost when using a powered prosthesis. This approach may
reveal muscle groups for training or strengthening, to improve metabolic reductions.
2.2 Methods
2.2.1 Participants
A total of 10 males (46.5 ± 14.9 years old) with unilateral transtibial amputation
(TTA) and 10 male, age-matched non-amputee controls participated in this study,
previously described in [49]. Inclusion criteria for the group with TTA included: >21.6
cm ground clearance on their prosthetic side, a well-fitting socket, the ability to walk
continuously for 20 minutes, and >6 months of prosthetic use. Exclusion criteria
for both groups included: self-reported body mass index (BMI) >35, uncorrected
vision or balance disturbance, or cardiovascular or neurological comorbidities that
prevented the safe completion of the walking protocol. Two participants used the
BiOM powered prosthesis as their regular device. Though BiOM owners may be more
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acclimated to the device and walk differently to non-owners, they were included to
maximize recruitment possibilities. All participants provided their written informed
consent prior to participating in this institutionally approved study.
2.2.2 Experimental Protocol
All participants came to a research laboratory for a single day of testing. After
shaving and cleaning the skin, we applied 16 surface electromyography (EMG) elec-
trodes (Delsys, Inc., Boston, MA, USA) according to [62]. Electrodes were placed
bilaterally on the gluteus medius (GM), rectus femoris (RF), vastus lateralis (VL),
vastus medialis (VM), lateral hamstrings (LH), medial hamstrings (MH), medial gas-
trocnemius (MG), lateral gastrocnemius (LG), soleus (SOL), and tibialis anterior
(TA). For participants with TTA, electrodes on the MG, LG, SOL, and TA were
placed on the intact limb only.
EMG data were collected at 1000 Hz as participants performed a series of max-
imum voluntary isometric contractions (MVCs) with the prosthesis donned. Knee
flexion and extension and ankle plantarflexion and dorsiflexion MVCs were tested
using a computerized dynamometer (CSMI, Stoughton, MA, USA), while all other
MVCs were tested using manual resistance and a handheld dynamometer (Lafayette
Instruments, Lafayette, IN, USA). For each muscle group, participants performed a
series of three submaximal contractions, separated by 30 seconds of rest, and a fi-
nal maximal 5-s volitional contraction for analysis. Knee position was set to 60◦and
30◦flexion for extension and flexion MVCs, respectively. For the hip abductors, par-
ticipants performed isometric hip abduction against resistance while lying on their
side, with the supporting leg bent for stability. The intact limb shank muscles were
tested while the participant lay prone with the knee extended. For the planarflexors,
the ankle was secured in neutral position, while for the dorsiflexors, the ankle was
in 30◦of plantarflexion. To isolate the soleus, participants were positioned on their
17
hands and knees, with the ankle in neutral position. Lower-leg muscles were mea-
sured on the intact limb only for participants with TTA and bilaterally for control
participants.
Participants with TTA were then randomly selected to be tested first with their
unpowered prosthesis or with a powered ankle prosthesis (BiOM T2 Ankle; BionX
Medical Technologies Inc., Bedford, MA, USA). A certified prosthetist fit the BiOM
to the participants’ existing socket and tuned it according to manufacturer guide-
lines. Details of the fitting and tuning process are provided in [49]. Participants
walked on a treadmill at a speed normalized according to a Froude Number of 0.16
to scale speed to each subject’s leg length [54]. Energetic costs were measured using
a portable metabolic system (Cosmed k4B2, Rome, Italy). All participants walked
on the treadmill for an 8-minute accommodation period. Once they achieved steady
state energy expenditure, defined as a respiratory exchange ratio <1.0 and a visible
plateau in oxygen consumption [30], they continued walking for an additional 3 min-
utes at steady-state. One participant with TTA was not able to reach steady state
energetics and was excluded from all analyses. Twelve reflective markers (18mm di-
ameter, ∼1mm base) were affixed on the shoe (2nd and 5th metatarsal, heel, and
lateral heel) and pelvis (bilateral anterior and posterior superior iliac spines) using
adhesive stickers. Marker positions were tracked at 100 Hz using a 10-camera motion
capture system (Vicon, Hauppauge, NY, USA) and electromyography was recorded
at 1000 Hz during all trials.
2.2.3 Data Analyses
Metabolic cost of transport (COT) was calculated as the steady state energy ex-
penditure normalized by walking speed and body mass [49]. EMG data were first
visually inspected for motion artifacts then band-pass filtered between 20-400 Hz, de-
meaned, and full wave rectified. A 4th order low-pass Butterworth filter with a cut-off
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frequency of 6 Hz was used to obtain linear EMG envelopes [22]. We then normalized
the linear envelopes to the peak EMG signal obtained during each muscles’ MVC
[60]. The gluteus medius was normalized to the maximum EMG amplitude across
conditions, due to the high variability in the MVCs for this muscle. To segment the
data into phases in the gait cycle, heel-strikes and toe-offs were identified using a ve-
locity detection algorithm [162]. Additionally, foot-adjacent instances were identified
by detecting sagittal-plane intersections of lateral heel markers during stance.
We calculated integrated EMG (iEMG) as the area under the normalized linear
envelope for the full gait cycle and within specific phases: early stance (heel-strike –
foot-adjacent), late stance (foot-adjacent – toe-off), and swing (toe-off – heel-strike).
For each participant, we analyzed the last 80 strides at steady state energy expen-
diture. We also measured co-contraction of antagonist muscle groups using a co-








where EMGant denotes the EMG signal of the antagonist muscle, EMGago denotes
the EMG signal for the agonist muscle, and EMGmin is the lower of the two (ago-
nist/antagonist) signals at each sampling point [100]. CCIs were calculated for the
bilateral RF-LH pair for loading response (ipsilateral heel-strike – contralateral toe-
off), terminal stance (contralateral heel-strike – ipsilateral toe-off), and late swing
(contralateral mid-stance – ipsilateral heel-strike), and for the intact TA-MG pair
during loading response only [137].
We excluded signals with excessive noise due to movement artifact, likely due
to electrodes loosening due to perspiration. On the intact side, one GM sample was
excluded. The excluded samples for the residual side are as follows: RF (n = 2), VL (n
= 1), VM (n = 3), and LH (n = 1). The residual side VM was particularly susceptible
to motion artifact due to it often being placed under the prosthetic socket liner. This
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sensor was removed if it caused discomfort or hindered participants’ movements.
2.2.4 Statistical Analyses
The dependent measures were iEMG of each muscle and CCI for muscle pairs.
We tested for differences between controls and people with TTA using unpowered
and powered prostheses using a series of linear mixed models, where controls was the
reference condition and subjects was a random effect. As there were no differences
between left and right sides for controls (paired t-tests, p >0.143), we used the side
corresponding to the intact side of their age-matched participant with TTA. Pair-
wise group comparisons were made using estimated marginal means within the linear
mixed model. To control for Type-I error, these post-hoc comparisons were only made
when the linear mixed model had a significant fixed effect. We also calculated the rela-
tionships between changes in cost of transport (∆COT = COTpowered - COTunpowered)
and changes in muscle activity (∆iEMG = iEMGpowered - iEMGunpowered) and between
∆COT and changes in CCIs, using a series of Pearson’s correlations. Significance was
set to p <0.05 for all comparisons.
2.3 Results
2.3.1 iEMG Across the Gait Cycle
There were significant fixed effects for the intact limb GM (p = 0.001), VL (p =
0.007), and TA (p = 0.031), and residual limb RF (p = 0.013), VL (p = 0. 010),
VM (p < 0.001), and LH (p = 0.004). Participants using the powered prosthesis had
greater iEMG over the gait cycle in the intact limb GM (p = 0.002), and residual limb
VM (p = 0.013; Figure 2.2) compared to that of the unpowered prosthesis. Compared
to controls, people with TTA had greater iEMG with both prostheses in the intact
limb VL (p < 0.016) and TA (p < 0.015), and the residual VL (p < 0.04), VM (p <
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0.019), and LH (p < 0.009). There was also greater activity in the intact limb GM (p
= 0.028; Figure 2.2) and the residual limb RF (p = 0.007) for the powered prosthesis
only.
2.3.2 Muscle Activity during Early Stance
During early stance, there were significant fixed effects for the intact limb GM (p <
0.001), VL (p = 0.004), and TA (p = 0.004), and residual limb GM (p = 0.048), RF (p
< 0.001), VL (p = 0.005), VM (p < 0.001), and LH (p = 0.008). Post-hoc pairwise
comparisons revealed that when wearing the powered prosthesis, participants had
greater iEMG in the intact limb GM (p < 0.001) and residual limb VM (p = 0.029)
compared to that of the unpowered prosthesis (Figure 2.3). Compared to controls,
people with TTA had greater iEMG with both prostheses in the intact limb VL (p <
0.004) and TA (p < 0.003), and residual limb RF (p < 0.001), VL (p < 0.028), VM
(p < 0.010), and LH (p < 0.005). There was also greater activity in the intact limb
GM (p = 0.007) and residual limb GM (p = 0.024) with the powered prosthesis only.
During the loading response phase specifically, there were no significant fixed effects
for co-contraction in any muscle pairs in either limb (p > 0.067).
2.3.3 Muscle Activity during Late Stance
During late stance, there were significant fixed effects for the intact limb GM (p
= 0.010) and residual limb MH (p = 0.006) and LH (p = 0.014). Compared to the
unpowered prosthesis, participants using the powered prosthesis had greater iEMG
in the intact limb GM (p = 0.033; Figure 2.3). Compared to controls, people with
TTA had greater iEMG with both prostheses in the residual limb MH (p < 0.010).
There was also greater activity in the intact limb GM (p = 0.022) and residual limb
LH (p = 0.008) with the powered prosthesis only. During terminal stance specifically,
there were significant fixed effects in the RF-LH co-contraction index in the intact (p
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Figure 2.1: Normalized EMG linear envelopes over the gait cycle
EMG linear envelopes averaged over all control participants (black) and participants
with TTA using unpowered (red), and powered (blue) prostheses, for intact (solid
line) and residual (dashed line) sides. Toe-offs for each condition are plotted as a
vertical line.
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Figure 2.2: Integrated EMG (iEMG) over the entire gait cycle
Average iEMG over gait cycle for control participants (black) and participants with
TTA using the unpowered (red) and powered (blue) prostheses for the intact (solid)
and residual (striped) limbs. Error bars are the standard deviations across
participants. Significant differences from controls (*), between prostheses for the
intact limb (†) and residual limb (‡) are indicated.
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Figure 2.3: Integrated EMG (iEMG) in distinct phases of gait
Radar plots of the iEMG for all muscles during early stance, late stance, and swing
phases. Data is shown for control participants (black) and participants with TTA
using the unpowered (red) and powered (blue) prostheses. Significant differences
between prostheses (†), between unpowered prostheses and controls (*) and powered
prostheses and controls (§) are indicated.
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= 0.013) and residual (p < 0.001) limbs. With the powered prosthesis, participants
had greater co-contraction (p = 0.007; Figure 2.4A) in the intact thigh compared
to the unpowered prosthesis. Compared to controls, people with TTA had greater
co-contraction with both prosthesis in the residual limb (p < 0.001).
2.3.4 Muscle Activity during Swing
During swing, there were significant fixed effects in the intact limb GM (p =
0.037) and LH (p = 0.037). Participants using the powered prosthesis had greater
iEMG in the intact limb GM (p = 0.015) and lower iEMG in the intact limb LH (p
= 0.017) compared to that of the unpowered prosthesis (Figure 2.3). During the late
swing phase specifically, there were no significant fixed effects for co-contraction for
any muscle pair in either limb (p > 0.122; Figure 2.4A).
2.3.5 Correlations between Muscle Activity and Metabolic Cost
Changes in the intact limb MG-TA co-contraction were moderately correlated
with ∆COT during loading response (r = -0.464, p = 0.208). Though not significant,
there were also moderate and strong correlations between ∆COT and residual limb
RF-LH co-contraction during terminal stance (r = -0.585, p = 0.168) and late swing
(r = -0.754, p = 0.050; Figure 2.4B), respectively. There were no significant correla-
tions between changes in muscle activity and ∆COT between prostheses (Figure 2.5).
However, there was a strong negative correlation between ∆iEMG of the residual RF
and ∆COT (r = -0.627, p = 0.132). There were also moderate correlations between
∆iEMG of the residual GM (r = 0.543, p = 0.131) and MH (r = -0.537, p = 0.136)
and ∆COT.
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Figure 2.4: Co-contractions and their relationships with metabolic cost
A) Co-contraction indices for the medial gastrocnemius – tibialis anterior (MG –
TA) and rectus femoris – lateral hamstring (RF – LH) muscle pairs in different gait
phases. Data for control participants (black) and participants with TTA using
unpowered (red) and powered (blue) prostheses are shown. The intact side is
plotted as solid colors and the residual side is plotted as stripes. Error bars are the
standard deviations across subjects. Significant differences from controls (*) and
between prostheses (†) are indicated. B) Linear correlations between changes in cost
of transport (∆COT) and changes in co-contraction indices (∆CCI). Linear fits are
shown for moderate and strong correlations. Data in the third quadrant
(highlighted in green) indicate a lower metabolic costs and lower co-contraction with
the powered, compared to unpowered prosthesis. Data for the two participants who
owned the powered ankle are indicated by closed symbols.
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Figure 2.5: Relationships between metabolic cost and muscle activity
Linear correlations between changes in cost of transport (∆COT) and changes in
integrated EMG (∆iEMG) for five muscle groups in the intact limb (top two rows)
and three muscle groups in the residual limb (bottom row). The quadriceps muscle
group included the rectus femoris (RF), vastus lateralis (VL), and vastus medialis
(VM). The medial hamstring (MH) and lateral hamstring (LH) muscles made up
the hamstrings group. The plantarflexor group consisted of the lateral
gastrocnemius (LG), medial gastrocnemius (MG), and soleus (SOL). Changes for
each participant are plotted as separate points. Linear fits are shown for moderate
and strong correlations. Data in the third quadrant (highlighted in green) indicate
lower metabolic costs and lower muscle activity with the powered, compared to
unpowered prosthesis. Data for the two participants who owned the powered ankle
are indicated by closed/bold symbols.
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2.4 Discussion
Participants with TTA had greater muscle activity in the intact limb gluteus
medius and residual limb vastus medialis when walking with the powered prosthesis
compared to the unpowered prosthesis and controls. While the gluteus medius had
increased activation in all phases of the gait cycle (early stance, late stance, swing),
the increase in the vastus medialis occurred primarily in early stance (Figure 2.3).
One functional role of the gluteus medius is to provide pelvic support during stance
[2]. Higher activity in the intact gluteus medius was likely necessary to counter-
act the increased rotational inertia of the swinging prosthetic limb. Specifically, the
powered ankle is heavier, which can create a greater external moment during swing.
Additionally, the prosthetic limb’s swing trajectory may be altered by the addition
and direction of supplied power, which may not be purely directed sagitally as most
prostheses are aligned with some degree of toe-out. Increased activity of the residual
vastus medialis during early stance could suggest an increased need for stabilization
during weight acceptance. This could be attributed to the powered ankle’s keel al-
lowing for a smaller range of passive deflection and/or a compensation for decreased
comfort relative to unpowered prostheses.
Activity of several residual limb muscles were moderately correlated with changes
in metabolic cost. Specifically, decreased metabolic cost was correlated with decreased
gluteus medius activity and increased rectus femoris activity. The relationship be-
tween residual gluteus medius activity and metabolic cost may reflect that those who
were able to reduce their metabolic cost had less need for frontal-plane stabilization
using the powered prosthesis. In contrast, the increasing residual limb rectus femoris
activity may represent an effective strategy to stiffen the knee such that the person
was able to better utilize ankle power. Increased medial hamstring activity was also
correlated with decreased metabolic cost. This may be a strategy to resist excessive
leg swing, thus decreasing energy loss during the subsequent loading response and
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consequently decrease metabolic cost [120]. However, it is important to note that the
small-sample correlation analysis presented here is exploratory and can be heavily im-
pacted by an individual outlier. In this case, the correlations between metabolic cost
and gluteus medius and medial hamstring activity were driven by a single participant
with the largest increase in metabolic cost. This individual exhibited a hip-hiking
gait, resulting in a hyperactive gluteus medius, which was exacerbated by use of the
powered ankle. When this participant was excluded from the correlation, increased
gluteus medius activity correlated with decreased metabolic cost (r = -0.622, p =
0.100) and medial hamstring activity was not correlated with changes in metabolic
cost (r = -0.148, p = 0.727).
There were few differences in muscle co-contraction between the two prostheses.
The only significant difference occurred in the intact limb thigh muscles during ter-
minal stance, where co-contraction was greater when walking with the powered com-
pared to unpowered prostheses (Figure 2.4A). This co-contraction may reflect the
need for stability when the prosthetic limb was swinging due to the heavier weight
and greater inertia of the powered foot. There were two non-significant, correlations
between muscle co-contraction and metabolic cost. Increased residual limb thigh mus-
cle co-contraction during terminal stance and late swing correlated with decreased
metabolic cost (r = = -0.585 and -0.754, respectively). Thigh co-contraction may
minimize energy loss in the socket-limb interface and more effectively transfer power
to the body’s COM during stance [76]. It may also prevent excessive leg swing [120].
It is important to note that the co-contraction indices used here are not unique and
other approaches may lead to different findings. However, we chose this specific mea-
sure as it is well suited to analysis in specific phases of the gait cycle [83].
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2.4.1 Limitations
This study had several limitations. First, participants in this study used their
own, clinically prescribed, unpowered prosthesis. The lack of consistent differences
in muscle activity between prostheses may be attributed to the variety of prostheses
they were prescribed [49]. As there is insufficient research on neuromuscular responses
to varying prosthetic characteristics to know how much this may affect study out-
comes, we chose to use the device they were comfortable with and acclimated to,
rather than have all participants wear the same unpowered foot. Second, while 10
participants completed the study, motion artifact in the EMG reduced the sample
size for some muscles to only 6 or 7. Some participants also had difficulty in con-
tracting specific muscles during MVCs, which led to several outliers for peak EMG.
These values were not excluded, as the study used a paired, within-subject statistical
approach. However, this does contribute to variability in the between-subject aver-
ages. Third, the changes in metabolic cost between prostheses in our participants
were mostly small, with only three participants falling below the within-day minimal
detectable change of 0.022 J/Nm [30]. Thus, it is possible we would observe stronger
correlations with a more diverse cohort with more varied responses. While the lack
of metabolic changes could be attributed to participants being instructed to walk at
a (potentially unnatural) fixed speed rather than their self-selected speed, the two
speeds were not significantly different. Further, there was no metabolic difference
between prostheses when assessed at the self-selected speed [49]. Lastly, there were
differences in acclimation time across participants as two owned and regularly wore
the powered ankle prosthesis (> 6 months), while the others were fit with the pow-
ered prosthesis and tested on the same day (acclimation ≥ 15 minutes). It is possible
that changes in neuromuscular control take time and experience to develop. How-
ever, even with a prolonged acclimation time, participants who owned the BiOM had
disparate metabolic responses to the added ankle power (Figure 2.4 and 2.5). This
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suggests that acclimation time alone is not what influences metabolic or neuromus-
cular adaptations and future studies should explore more device-specific acclimation
schemes.
2.5 Conclusion
This study explored the effect of powered ankle prostheses on muscle activity dur-
ing walking. When walking with a powered prosthesis, participants increased activity
in muscles that provide support during stance. Thus, exploring training paradigms
that strengthen stabilizing muscles may benefit powered prosthesis users’ ability to
accommodate the heavier powered ankle. Changes in muscle activity between pow-
ered and unpowered devices were correlated with changes in metabolic cost. While
these correlations were not significant in this small cohort, they provide potential
targets for device-specific biofeedback training. Future studies should further explore
these relationships in a larger cohort with longer accommodation times.
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CHAPTER 3
Determine If the Addition of Prosthetic Ankle
Power Delays the Onset of Muscular Fatigue
During an Extended Bout of Walking
3.1 Introduction
The primary goal of rehabilitation post-amputation is a return to pre-amputation
lifestyles, including the ability to take part in healthy amounts of physical activity [89].
To promote independent bipedal ambulation after a transtibial amputation (TTA),
patients are prescribed a prosthesis, as part of the rehabilitation process. However,
compared to people without amputation, people with TTA take fewer steps at a time
(< 17 steps) and are less physically active overall [88]. A sedentary lifestyle can lead to
increased risk of cardiovascular diseases [101] and a lower quality of life [116]. People
with TTA rely more on their intact limb and walk with asymmetric step lengths and
ground reaction forces [133, 142]. People with TTA also walk with increased muscle
activity in the residual limb hamstrings and vasti muscles [118, 74, 134, 40], which
contribute to a higher metabolic effort when walking [155]. Further, the overreliance
on the intact side ankle subsides only after a prolonged duration of walking, at which
point the power generated at the bilateral hip joints increase to compensate for the
decreased power generation at the intact side ankle [160]. Therefore, providing active
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push-off at the prosthetic foot may yield a more symmetric gait, delay the onset of
fatigue, and mitigate the barrier to prolonged physical activity in everyday life.
For most people with TTA, they are prescribed either solid ankle cushion heel
(SACH) or dynamic response (DR) feet, both of which are passive and do not perform
positive net work. Powered prosthetic feet were developed to mimic the ankle by
providing assistive push-off power [7]. The powered prosthesis has been shown to
increase the prosthetic ankle’s range of motion (ROM) and power generation during
gait [38]. The powered push-off has contributed to the ability to walk with decreased
metabolic effort in some participants [63, 130], though this finding is inconclusive in
participant cohorts with greater age ranges [49, 102]. However, all previous studies
observed gait for short duration walking (3-5 minutes). Further, changes in metabolic
effort between unpowered and powered prostheses were not correlated to changes in
everyday step count [Chapter 5], which suggests that the metabolic response to the
powered push-off by itself may not explain or predict the potential benefits during
prolonged walking bouts. Therefore, to understand whether a powered prosthesis will
enable people with TTA to walk for longer, there is a need to explore how a fatiguing
bout of walking affects their joint mechanics.
The effects of a powered push-off on mitigating fatigue has not yet been explored.
In fact, the effects of lower-limb fatigue on people with TTA has only been reported
in one previous study [160]. In this study, people with TTA walked at a self-selected
speed with unpowered prostheses for a total of 60 minutes to induce lower-limb mus-
cular fatigue. Authors speculated that fatigue in the intact plantar flexor muscles
contributed to the decrease in the power absorbed and generated at the intact side
ankle, which was compensated by increased knee moments in loading response to
progress the body forward and increased power generated at the hip joint to facilitate
forward propulsion. Similar to people with TTA, people with Charcot-Marie-Tooth
disease walk with increased reliance on their hip flexors to compensate for their distal
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limb weakness. In people with Charcot-Marie-Tooth disease, fatigue at the hip flexor
muscles were found to limit walking duration [121].
The primary purpose of this study was to quantify the effectiveness of a powered
prosthesis on mitigating the onset of fatigue. Our central hypotheses were that with a
powered ankle providing assistive push-off, people with TTA would be able to walk for
a longer duration and report a lower rating of perceived exertion during the fatiguing
walking bout. We will also examine joint mechanics before and after the fatiguing
walking bout, to provide insight into how the added push-off power might affect gait
mechanics over time. The powered prosthesis contributing to forward propulsion
may delay the onset of fatigue at the intact ankle plantar flexors and reduce power
compensations at other joints. Thus, we hypothesize that the increase in hip power
generation after fatigue will be lower with a powered prosthesis, relative to with
an unpowered prosthesis. Exploring changes to joint mechanics before and after a
fatiguing walking bout could lend insight into the limiting factors to long duration
walking and if those factors persist with a powered push-off.
3.2 Methods
3.2.1 Participants
We recruited twelve individuals with unilateral transtibial amputation from the
local community to participate in the study (Table 3.1). Inclusion criteria were age of
21 years or older, unilateral transtibial amputation, and prosthesis use of at least six
months. Exclusion criteria were a history of neurological or orthopedic disorders to
the intact limb, history of cardiovascular disease, or an inability to walk independently
for 10 minutes. Participants provided written informed consent prior to taking part
in the study. Two participants did not complete the study due to unrelated personal
or health issues.
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Table 3.1: Participant demographics
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3.2.2 Protocol
The protocol followed a crossover design in which participants were tested with the
two types of prosthetic feet (unpowered and powered). Five individuals were tested
with their prescribed, unpowered prosthesis and five individuals were tested with the
powered device (BiOM T2, Ottobock, Duderstadt, Germany) first (Table 3.1). Of the
ten participants who completed the study, two used the BiOM as their main, everyday
prosthesis. After a fitting session with a certified prosthetist, participants wore each
prosthesis at home for an acclimation time of at least three weeks. Consequently,
data collection for each type of prosthesis occurred on separate days.
First, participants walked over ground along a 7-meter walkway at a fixed speed
based on their leg length [54] (PRE). We recorded walking speed using infrared timing
gates, spaced approximately 3 meters apart, and trials were included if the walking
speed was within 5% of the target speed. One participant (S03) could not walk at
the fixed speed, and walked at their slower, self-selected speed. During this phase,
participants were given ample time to rest or sit down as needed. To test their
endurance, participants then walked on the treadmill at a fixed, faster speed (110%
of their fixed speed on a 0% incline for K3 and 5% incline for K4 participants) until
they felt they could no longer continue. The faster walking speed was chosen to
maximize the potential benefits of the powered prosthesis, as previous studies found
metabolic reductions for the powered prosthesis in fast walking speeds but not in
slow speeds [7, 63]. Two participants (S04, S07) felt uncomfortable walking at their
assigned faster fixed speed and walked at a slightly slower speed, which was held
consistent for both prosthesis types. At every minute of the endurance walking bout,
we recorded participants’ heart rate via a heart rate monitor and rating of perceived
exertion (RPE) based on a modified 10-point Borg scale [14]. Heart rate and RPE
were also recorded immediately before and after the treadmill walking bout. Following
the treadmill walk, the duration of walking was recorded and participants were given
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a short amount of time (< 2 minutes) to acclimate themselves to over ground walking.
Finally, participants once again walked over ground at their fixed speeds (POST).
We recorded kinematic and kinetic data during both phases (PRE and POST) of
the protocol at 120 Hz, using a motion capture system (Motion Analysis, Rohnert
Park, CA). Reflective markers were placed on participants’ C-7 and T-8 vertebrae,
sternal notch, xiphoid process, and bilaterally on the acromion, iliac crest, anterior
superior iliac spine, posterior superior iliac spine, greater trochanter, medial and
lateral femoral condyles, medial and lateral malleoli, heel, lateral heel, 5th and 2nd
metatarsals. Additionally, we placed clusters of four markers bilaterally on the lateral
side of the thigh and shank segments. We used embedded force plates to collect ground
reaction force data and calculate joint kinetics at the hip, knee, and ankle bilaterally.
3.2.3 Data Analysis
Kinematic and kinetic data were low-pass filtered using a 4th order Butterworth
filter with a 6 Hz cut-off frequency. We analyzed five fixed-speed trials of walking,
where the participant’s entire foot landed on the force plate during the stance period.
The gait cycle was segmented with heel strikes in Visual 3d (C-Motion, Inc., Ger-
mantown, MD). Joint ROMs were assessed over the entire gait cycle. Positive and
negative peaks for joint power were addressed over specific phases of the gait cycle
(Figure 3.1). Joint kinematics and mechanics in the sagittal plane were averaged
across the five trials for each prosthesis type.
3.2.4 Statistical Analysis
Primary dependent measures were the duration of fast-speed treadmill walking
and the time at which the participant’s RPE exceeded a value of 5 (“Hard”). We
tested for differences between the two prostheses (unpowered, powered) using a series
of paired t-tests. Secondary dependent measures were sagittal-plane peak power
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Figure 3.1: Relevant phases of the gait cycle for joint power
Phases of the gait cycle, in which positive (generation) and negative (absorption)
power peaks were assessed.
generated and absorbed at the hip, knee, and ankle joints, ground reaction force
peaks for each side, sagittal-plane ROM at the hip, knee, and ankle joints, step times
and lengths, and symmetry indices for each measure. We calculated symmetry indices





where xprosthetic is the measure at the residual limb and xintact is the measure at
the intact limb. A positive SI indicates greater values in the residual limb, a negative
SI indicate greater values in the intact side, and a 0% SI indicates perfect symmetry.
We tested for fixed effects in the prosthesis (unpowered, powered) and fatigue (PRE,
POST) factors and an interaction effect (prosthesis × fatigue) using a series of linear
mixed models, with subjects as a random factor. If there was a significant interaction
effect, post-hoc, pair-wise comparisons were made using estimated marginal means
within each linear mixed model. We controlled for Type-I error by making these
post-hoc comparisons only if the linear mixed model had a significant effect. Because
EMG signals for unpowered and powered prostheses were recorded on separate days,
we did not compare iEMG and peak EMG between prostheses directly. Instead, we
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tested for differences between prostheses in the changes in muscle activation pre- and
post-fatigue using a series of paired t-tests. Significance was set to p < 0.05 for all
comparisons. To address the small sample size, we also calculated the effect sizes for












(SD2Powered(nPowered − 1)) + (SD2Unpowered(nUnpowered − 1))
nPowered + nUnpowered − 2
where Mx is the mean of group x, SDpooled is the pooled standard deviation, N is
the sample size, SDx is the standard deviation within group x, and nx is the sample
size of group x [36]. A small effect is represented by 0.2 ≤ g ≤ 0.5, a medium effect
by 0.5 ≤ g ≤ 0.8, and large effect by g ≥ 0.8 [23].
3.3 Results
3.3.1 Walking Duration and Perceived Exertion
Participants walked on the treadmill at 110% of their leg length-based walking
speed (1.30 ± 0.09 m/s). There was no difference between unpowered and powered
prostheses in how long participants were able to walk on the treadmill (p = 0.165,g=
-0.107; Figure 3.2A). For some participants, lower-limb fatigue was not the primary
reason they could no longer keep walking. With the unpowered prosthesis, seven
participants reported having to stop walking due to stump pain (n = 6), phantom
pain (n = 1), or hip pain (n = 1), rather than due to fatigue (n = 1). With the
powered prosthesis, three participants stopped due to stump pain, rather than due
to fatigue (n = 6). Further, we stopped two participants’ (S04, S07) treadmill walks
39
Figure 3.2: Walking endurance and perceived exertion
A. Walking duration and B. Time at which ratings of perceived exertion (RPE)
exceeded 5. Individual trends were plotted as grey dotted lines.
at 30 minutes due to concerns about wounds forming at the residual limb. However,
excluding those two participants did not change results (p = 0.168,g= -0.048). There
was also no difference between prostheses in the time at which participants’ RPE
exceeded a value of 5 (p = 0.643,g= -0.155; Figure 3.2B). One participant’s RPE
never reached 5 and was excluded from analysis.
3.3.2 Spatiotemporal Parameters
Participants’ step times on their residual limb was shorter with the powered pros-
thesis relative to the unpowered prosthesis (p = 0.012; Figure 3.3). With the powered
prosthesis, participants also took longer steps (p < 0.001) and had longer stance times
(p = 0.009) on their residual limbs. Step lengths were less symmetric (p = 0.001),
while stance times were more symmetric (p = 0.003) with the powered prosthesis.
There was no prosthesis × fatigue interaction effect in any spatiotemporal parame-
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Figure 3.3: Spatiotemporal parameters before and after fatigue
Step lengths, step times, stance times, and symmetry indices (SI) for each
parameter. Significant prosthesis effects (*) were denoted.
ters.
3.3.3 Ground Reaction Forces (GRF)
The peak braking force in the anterior-posterior GRF was greater in the residual
limb when walking with the powered prosthesis relative to the unpowered prosthesis
(p = 0.044; Figure 3.4). There was also a significant prosthesis × fatigue effect for
the symmetry indices of the peak propulsive GRF (p = 0.041). Peak propulsive GRF
was less symmetric after fatigue when walking with the unpowered prosthesis (p =
0.024;g= -0.225). Further, after fatigue, peak propulsive GRF was more symmetric
with the powered prosthesis compared to the unpowered prosthesis (p = 0.001;g=
0.333).
In both the intact limb, the first peak of the vertical GRF was greater with the
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Figure 3.4: Ground reaction forces (GRF) before and after fatigue
GRF and symmetry indices (SI) for peaks in the anterior-posterior (AP), vertical
(V), and mediolateral (ML) directions. Significant prosthesis effects (*) were
denoted. If the prosthesis × fatigue interaction effect was significant, significant
pairwise differences between pre- and post-fatigue with the unpowered prosthesis (†)
and significant pairwise differences between prostheses post-fatigue ($) were
denoted.
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unpowered prosthesis relative to the powered prosthesis (p = 0.006), while in the
residual limb, this peak was greater with the powered prosthesis (p < 0.001; Figure
3.4). The first peak of the vertical GRF was also more symmetric with the powered
prosthesis (p < 0.001). In the residual limb, the second peak of the vertical GRF was
lower with the powered prosthesis (p < 0.001). The second peak of the vertical GRF
was less symmetric with the powered prosthesis relative to the unpowered prosthesis
(p < 0.001). There was no prosthesis × fatigue interaction effect in the vertical GRF
peaks.
3.3.4 Joint Mechanics
At the residual limb hip, peak power generated during pre-swing was lower when
walking with the powered prosthesis relative to the unpowered prosthesis (p = 0.004;
Figure 3.5). The peak power generated during pre-swing was also less symmetric with
the powered prosthesis (p = 0.006; Figure 3.6). There was a significant prosthesis
× fatigue effect for peak power generated during pre-swing at the residual limb hip
(p = 0.002). Post-hoc pairwise comparisons revealed that power generated increased
after fatigue when walking with the unpowered prosthesis (p = 0.041;g= 0.238) but
decreased after fatigue when walking with the powered prosthesis (p = 0.016;g= -
0.238; Figure 3.3). There was also a significant prosthesis × fatigue effect for the
symmetry indices of peak power generated during pre-swing (p = 0.008). Hip power
generated during pre-swing was less symmetric after fatigue when walking with the
powered prosthesis (p = 0.0082;g= -0.264). Symmetry in hip power generation was
not different pre- and post-fatigue with the unpowered prosthesis (p = 0.262;g=
0.194).
At the residual limb knee, the peak power generated during terminal stance was
lower (p < 0.001) and the peak power absorbed during pre-swing was greater (p <
0.001) when walking with the powered prosthesis, relative to with the unpowered
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Figure 3.5: Sagittal joint mechanics for the hip, knee, and ankle joints
For the hip and knee, mid-stance (MS), terminal stance (TS), and pre-swing (PSw)
phases of gait were highlighted. For the ankle loading response (LR), TS, and PSw
phases of gait were highlighted. Significant prosthesis effects (*) and significant
fatigue effects (♦) were denoted. If the prosthesis × fatigue interaction effect was
significant, significant pairwise differences between pre- and post-fatigue with the
unpowered prosthesis (†) and with the powered prosthesis (‡) and significant
pairwise differences between prostheses post-fatigue ($) were denoted.
44
prosthesis (Figure 3.5). The peak power absorbed during pre-swing was also more
symmetric when walking with the powered prosthesis (p = 0.005; Figure 3.6). There
was no prosthesis × fatigue interaction effect in any of the phases of gait observed.
At the ankle, the peak power absorbed during loading response was greater with
the powered prosthesis relative to with the unpowered prosthesis, for both the intact
(p < 0.001) and residual limbs (p = 0.002; Figure 3.5). There was also a significant
fatigue effect, as the power absorbed during loading response at the intact limb ankle
was greater post-fatigue, relative to pre-fatigue (p = 0.004). In the residual limb
ankle, the peak power absorbed during terminal stance was lower (p < 0.001) and
the peak power generated during pre-swing was greater (p < 0.001) with the powered
prosthesis relative to the unpowered prosthesis. During terminal stance, the power
absorbed at the ankle was less symmetric with the powered prosthesis relative to with
the unpowered prosthesis (p < 0.001; Figure 3.6). During pre-swing, however, the
power generated at the ankle was more symmetric with the powered prosthesis (p <
0.001). There was no prosthesis × fatigue interaction effect in any of the phases of
gait observed.
3.3.5 Joint Range of Motion (ROM)
Residual side hip joint ROM was lower with the powered prosthesis relative to the
unpowered prosthesis (p < 0.001; Table 3.2). Hip ROM was also less symmetric with
the powered prosthesis (p = 0.003). There was a significant prosthesis × fatigue effect
for the residual limb hip ROM (p = 0.005). The residual limb hip ROM decreased after
fatigue when walking with the powered prosthesis (p = 0.022;g= -0.197), while it was
unchanged after fatigue when walking with the unpowered prosthesis (p = 0.085;g=
0.147). Further, after fatigue, hip ROM was lower with the powered prosthesis relative
to the unpowered prosthesis (p < 0.001;g= -0.480).
Residual limb knee joint ROM was greater with the powered prosthesis relative to
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Figure 3.6: Joint mechanics symmetry during specific phases of the gait cycle
Significant prosthesis effects (*) were denoted. If the prosthesis × fatigue
interaction effect was significant, significant pairwise differences between pre- and
post-fatigue with the unpowered prosthesis (†) and with the powered prosthesis (‡)
were denoted.
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Table 3.2: Joint range of motion (ROM) and symmetry indices (SI)
the unpowered prosthesis (p = 0.001; Table 3.2). Knee ROM was also more symmetric
with the powered prosthesis (p = 0.001). There was a significant prosthesis × fatigue
effect for the symmetry indices of ROM at the knee (p = 0.037). After fatigue,
knee ROM was less symmetric with the powered prosthesis relative to the unpowered
prosthesis (p < 0.001;g= 0.337).
The residual limb ankle ROM was greater with the powered prosthesis relative
to the unpowered prosthesis (p < 0.001; Table 3.2). Additionally, ankle ROM was
more symmetric with the powered prosthesis (p < 0.001). There was no prosthesis ×
fatigue interaction effect in ankle ROM.
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3.4 Discussion
3.4.1 Walking Endurance and Perceived Exertion
Our central hypotheses that adding the powered push-off would increase partici-
pants’ walking endurance and decrease their perceived exertion during walking were
not supported. While the intent of the experiment was for participants to walk at
a fast speed until they could no longer continue due to muscular fatigue, there were
several pain-related reasons that limited participants from walking for longer. With
the unpowered prosthesis, only one participant reported having to stop due to fatigue,
with others having to stop due to phantom pain, pain at the residual stump, or at the
hip. Though the time of walking did not change with the powered prosthesis, more
participants were able to walk until they were fatigued, rather than in pain. Though
there were no differences in the time at which participants’ rating of perceived ex-
ertion (RPE) exceeded a 5 (“Hard”), their reasons for stopping may indicate that
the powered prosthesis was less painful to walk with, compared to the unpowered
prosthesis. This was supported by participants having longer stance times, greater
braking ground reaction force (GRF) peaks, and greater vertical GRF peaks on the
residual limb with the powered prosthesis. Further, the first vertical GRF peak at
the intact limb was lower with the powered prosthesis, suggesting the prosthesis may
have mitigated some of the overreliance on the intact limb. Because our study was
not designed to specifically evaluate or distinguish the effects of the powered push-off
on pain or comfort, this is an area that future research may explore.
3.4.2 Compensatory Mechanisms to Fatigue
Our findings support the secondary hypothesis that the increase in hip power
generation after fatigue would be lower with a powered prosthesis compared to an
unpowered prosthesis. With the unpowered prosthesis, the peak residual limb hip
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power generated during pre-swing increased post-fatigue relative to pre-fatigue, which
corroborate previous findings [160]. As expected, the intact limb ankle joint absorbed
less power during loading response regardless of prosthesis (Figure 3.5). This is
consistent with previous findings [160] and is a potential indicator of plantar flexor
fatigue, as fatigue associated with long-distance walking has been shown to reduce
eccentric contraction at the ankle [161]. With the powered prosthesis, however, peak
power generated at the residual limb hip did not increase post-fatigue. This suggests
that the powered prosthesis may have reduced the compensatory mechanics at the
hip joint, even if the intact limb ankle was eventually fatigued from walking.
The effects of fatigue and the powered push-off on residual limb hip joint mechan-
ics may warrant further investigation, as the residual limb hip in fact generated less
power after fatigue. This is an interesting finding, as the residual limb hip flexors
are considered a major contributor to forward propulsion [131]. In previous studies
quantifying joint power in individuals with TTA under non-fatiguing walking condi-
tions, the increased residual limb hip extensor power has been recognized as a major
contribution to forward propulsion [131, 164]. In another study comparing powered
and unpowered prostheses, hip power generated at the residual limb was not different
between prostheses [38]. In our study, participants’ joint mechanics responded differ-
ently to a fatiguing bout of walking depending on the prosthesis. With the powered
prosthesis, participants had a reduced peak power generation post-fatigue relative
to pre-fatigue. Additionally, when making the comparison between prostheses after
fatigue, peak hip power was lower with the powered prosthesis. These findings sug-
gest that participants may have adopted a gait strategy that derived greater forward
propulsion from the powered push-off after fatigue. However, there were no signif-
icant fatigue effects in joint angles at the hip, knee, or ankle that clearly illustrate
the adopted gait strategy (Figure 3.7). Thus, while subtle changes at the joints may
have propagated to result in changes at the residual limb hip mechanics, it is unclear
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Figure 3.7: Sagittal angles for the hip, knee, and ankle joints
Significant prosthesis effects (*) were denoted.
exactly how the element of fatigue and the powered push-off combined to manifest
in this reduction of hip power. It is worth noting that the post-hoc pairwise compar-
isons of residual limb hip power generation during pre-swing had small effect sizes (|g|
≤ 0.472; Appendix A.3). Future works with greater sample sizes may utilize EMG
measurements of muscle activations to elaborate on this finding.
The fatigue and prosthesis × fatigue interaction effects were not significant for
power generated and absorbed at the knee joint and for GRF peaks. This finding
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differs from previous work, in which participants reduced their intact limb propulsive
GRF peak after fatigue, compensated with an increased residual limb propulsive GRF
peak and increases in residual limb knee joint angles and moments in midstance [160].
These differences may be explained through differing protocols and prosthetic types.
Our participants walked at a target speed based on their leg length before and after
fatigue, whereas no target walking speed is specified in [160]. One reason we observed
no differences in propulsive GRF peaks before and after fatigue may be that walking
speed was set constant. Further, five of six participants in the previous study walked
with solid ankle cushion heel (SACH) feet and only one participant walked with a
dynamic response (DR) foot. All ten participants who completed our study walked
with a DR foot as their unpowered prosthesis. This discrepancy could explain the
absence of fatigue-related changes to knee power, ROM and GRF, as DR feet are more
compliant during loading response and provide greater peak push-off power compared
to SACH feet [157].
3.4.3 Propulsive GRF
Though the power generated at the prosthetic ankle did not change with fatigue
regardless of prosthesis, the symmetry of the propulsive GRF peaks was affected by
the prosthesis and fatigue interaction. With the unpowered prosthesis, propulsive
GRF was more less symmetric after fatigue, suggesting increased reliance on the
intact limb for forward propulsion, whereas this effect was not seen with the powered
prosthesis. When making the comparison post-fatigue, propulsive GRF was more
symmetric with the powered prosthesis compared to the unpowered prosthesis. This
may be an indication that participants were more limited by comfort or pain with
the unpowered prosthesis compared to the powered prosthesis.
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3.4.4 Ability to Provide Stance Stability
A potential area for improvement could be found by examining the ability of the
powered prosthesis to provide stance stability by absorbing power during terminal
stance. Power absorption during early to mid-stance serves the purpose of redirecting
the center of mass velocity as the contralateral limb generates power by pushing off
of the ground [34]. Compared to an unpowered prosthesis, the powered prosthesis
has been shown to absorb less power at the prosthetic ankle during terminal stance
[38]. Our results were consistent with previous findings in both the pre- and post-
fatigue conditions, and was further corroborated by the lower dorsiflexion peak of
the powered prosthetic ankle (Figure 3.7). The lack of stance stability with the
powered prosthetic ankle may be associated with increases in power absorbed at the
intact limb ankle during its loading response and at the residual limb knee during its
pre-swing. Further, more power was absorbed at the intact limb ankle post-fatigue
relative to pre-fatigue. Therefore, as participants became fatigued, they absorbed
more power in the intact limb ankle, potentially as a way to facilitate a smoother step-
to-step transition. The reduced power absorption at the prosthetic ankle may incur
compensatory increases in eccentric contractions at the intact limb ankle dorsiflexors
and residual limb hamstrings. While this finding was limited by a small sample size,
the post-hoc comparison had a medium effect size (g = -0.588). Thus, future work
should investigate the effects of the reduced power absorption at the prosthetic ankle
by quantifying accompanying changes in muscle activity.
3.4.5 Limitations
In our study, participants were instructed to walk on the treadmill at a pre-
determined fast speed for as long as they could, and the duration of walking was
used as a measure of endurance. The fast target walking speed was used because the
powered prosthesis had been shown to reduce metabolic costs in faster speeds but
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not at slower speeds [7, 63]. To ensure muscular fatigue, we instructed our one K4
participant to walk on a 5% incline, though may have placed larger moments at the
hip joint and altered the effects of fatigue . Additionally, the fast-speed walking may
have prompted more stoppages due to pain or discomfort, as participants may not
have been used to walking at fast speeds. However, fewer participants had issues of
pain and discomfort with the powered prosthesis, which may be a finding unique to
faster-than-comfortable walking speeds. Further, we were not able to control for or
measure the degree of muscular fatigue during the long-duration treadmill walk. The
duration of the walk, which would affect the extent to which muscular fatigue was
achieved, was dictated by the participant’s perceived exertion, and likely affected by
pain or discomfort. Future works may record EMG signals during maximal voluntary
contractions to control for the degree of fatigue across participants. Additionally, mea-
sures of endurance may have been more contextual to walking patterns in daily life if
participants walked at their self-selected speed during the fatiguing bout of treadmill
walking. Finally, our approach employed a pre- versus post-fatigue paradigm to com-
pare joint mechanics during overground gait. An instrumented treadmill capable of
recording ground reaction forces would enable researchers to observe the gradient of
changes to joint mechanics throughout the fatiguing bout of walking. Further, record-
ing muscle activity in the lower-limb muscles during the fatiguing bout of walking may
provide ways to quantify the onset of muscular fatigue.
3.5 Conclusion
In our study, the powered prosthesis reduced participants’ pain and discomfort at
the residual limb when walking for long durations. Findings also suggest that when
walking with the powered prosthesis, individuals with TTA may adopt a gait strategy
that relies more on the prosthetic ankle rather than the residual limb hip joint for
forward propulsion. However, participants were not able to walk for longer with the
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powered prosthesis, suggesting other limiting factors. It is possible that a lack of
power absorption at the prosthetic ankle may lead to compensations at the residual
limb knee and intact limb ankle. Further work is needed to elucidate the factors that
limit the user’s endurance when walking with the powered prosthesis.
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CHAPTER 4
Wearable Sensors Quantify Mobility in People
with Lower Limb Amputation During Daily Life1
4.1 Introduction
Rehabilitation after a lower limb amputation (LLA) typically focuses on restor-
ing bipedal ambulation and helping the individual return to their pre-amputation
lifestyles [37]. In spite of this goal, people with LLA are less physically active and re-
port decreased quality of life compared to healthy non-amputees [19, 155, 116]. One
potential reason for this may be inappropriate prosthetic prescription [1, 89, 115].
To prescribe prosthetic components, clinicians assess patients’ current and potential
functional capabilities in clinical settings using the Medicare Functional Classification
Level (K-level) [47]. The K-level guidelines classify patients into five activity levels,
from K0 (least mobile) to K4 (very mobile) [41]. Clinicians typically use patient
interviews to gather information about patient history, comorbidities, residual limb
health, and motivation to ambulate. This information, along with clinicians’ assess-
ment of the K-level guideline descriptors are used to assign patient K-levels [47, 80].
However, these guideline descriptors lack specific criteria or objective standards for
1A version of this chapter is published as Kim, J., Colabianchi, N., Wensman, J., & Gates, D. H.
(2020). Wearable Sensors Quantify Mobility in People With Lower Limb Amputation During Daily
Life. IEEE Transactions on Neural Systems and Rehabilitation Engineering, 28(6), 1282-1291.
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the clinicians who evaluate them [25, 80, 112, 46, 32]. Additionally, this system relies
on patient self-report, which has been shown to be unreliable [140]. As such, the
assignment process is subjective and has no published evidence of reliability [112].
Likely because of these factors, 67.8% of U.S. clinicians reported a lack of confidence
in the current system’s ability to accurately assign rehabilitation potential [15].
Previous studies have introduced methodologies to aid in prosthetic prescription
by moving away from self-report and toward measures of physical performance during
daily life [75, 4, 3]. These daily-life measures can be particularly beneficial in quan-
tifying factors such as level of community ambulation or regular physical activity.
While these are often assessed through patient interviews, questionnaires, or activity
diaries, these self-report methods rely on patient recall, and prior research has found
that people tend to overestimate their daily activity [140, 119, 147]. Furthermore,
there are likely differences between the individual’s capacity, as measured by in-lab
or in-clinic assessments, and the individual’s performance in daily life [115]. A more
holistic view of an individual’s functional mobility may include both their capacity
and actual daily life activity. As such, a growing number of studies measure functional
walking performance during daily life [149, 75, 148, 68, 65].
With the advent of wearable technology, it is now possible to objectively quantify
the amount of activity that people do in daily life. Previous works have used step
counts as a measure of mobility in people with lower limb loss using inexpensive
technology such as accelerometers and pedometers [140, 115, 138]. These studies have
found that people with LLA take fewer steps per day than healthy non-amputees or
the recommended 10,000 steps per day [88, 140]. While step count is a useful indicator
of quantity of physical activity and overall health [150], it lacks information about
the quality of the steps taken. Measures such as cadence and walking speed can
describe the quality of steps during daily life. Further, these measures paired with
the location of where the walking occurs may provide additional insight to clinicians
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Table 4.1: Participant demographics and data quantity
about functional mobility.
The ability or potential to vary cadence is an important part of function per
the K-level guidelines [41]. While cadence during daily life can be measured using
widely available, inexpensive sensors [88, 149, 112, 4], only one paper quantified the
variability of cadence during daily life. Arch et al. proposed a method to calculate
cadence variability using the Weibull scale parameter of each participant’s cadence
distributions [4]. In this method, a smaller scale parameter value indicated that most
of the cadence data were lower cadences, describing a person who did not walk at a
variety of cadences. They found that their K2 participants had lower scale parameters
than their K3 participants and thus walked with less variable cadence. However,
such commercial products will underestimate cadence if walking is not continuous
for the entire epoch [29]. Moreover, the simple accelerometer-based activity monitors
have decreased accuracy at slower walking speeds [43]. These issues are particularly
problematic for people with LLA as they tend to walk slowly and in short bouts
[88]. Therefore, more advanced sensors or signal processing techniques are required
to measure the distribution of cadence.
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Another key component of mobility is engagement in the community. Unfortu-
nately, there is no measurable standard for how well one engages in the community.
Community ambulation is typically assessed subjectively by the clinician, through
patient self-reports [80]. To quantify this criterion, several studies have examined
where healthy adults [127], older adults [156, 84], and people with LLA [75, 68, 69]
perform physical activity, typically using Global Positioning System (GPS) data in
concert with step counts. While this approach measures the number of steps taken in
the community, it may only provide indirect insight into how well people move within
community environments. A more comprehensive measure may be required in order
to assess community ambulation.
Walking speed has long been established as a robust indicator of community ambu-
lation in the stroke population [117] and a key factor in assessing mobility [5, 45, 64].
Examining walking speed across different locations could assist in assessing commu-
nity ambulation. Recent developments of Inertial Measurement Units (IMU) and
inertial navigation algorithms have made it possible to accurately calculate stride-by-
stride spatiotemporal parameters (such as cadence and walking speed) using small,
wearable sensors. This approach has been applied in the research setting, demon-
strating an error of 0.8% for fast walking and 0.3% for slow walking [109]. To our
knowledge, however, it has yet to be applied to the amputee population. While in-
clinic tests such as the 10-meter walk test can measure walking speed to quantify
a patient’s walking speed capacity, this likely does not represent their comfortable
walking speed in daily life [115].
The purpose of this study was to explore the clinical viability of using a system of
IMU and GPS sensors to characterize the functional mobility of people with LLA. We
measured cadence, walking speed, characteristics of their distributions, and how they
change with location. We used wearable sensors to measure patient walking during
their daily lives to provide a better understanding of everyday walking performance,
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Figure 4.1: Sensor setup and processing
Participants wore an IMU mounted on the prosthetic foot, an accelerometer (ACC)
on the prosthetic pylon (non-dominant limb for non-amputees) and carried a
GPS-enabled smartphone. We identified periods of non-sedentary activity from the
ACC. We then calculated the three-dimensional position of the foot using IMU data
during non-sedentary periods. From this, we calculated stride parameters including
stride length, cadence and speed. We then determined where this activity occurred
using time-synchronized GPS data.
in addition to in-lab capacity measures. Our secondary goal was to examine the
potential added value of ”everyday performance measures” as compared with in-lab
measures of capacity. Because everyday cadence variability and walking speed have
yet to be quantified using this method, we also recruited healthy, non-amputee adults
to provide a basis for comparison.
4.2 Methods
4.2.1 Subjects
We recruited 17 individuals (15 males; 47.9 ± 14.5 years old) with lower limb
amputation from the University of Michigan Orthotics and Prosthetics Center. Po-
tential participants were included if they were over the age of 18, had a lower limb
amputation, had been using a prosthesis for at least 6 months, and were able to walk
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independently. Of these individuals, two were classified as K2, 13 as K3, and two as
K4 (Table 4.1). We also recruited 14 healthy, non-amputee controls (13 males; 44.2
± 14.8 years old) through an online database (http://umhealthresearch.org). Par-
ticipants were screened to ensure that they did not have any history of neurological
diseases or injuries that would affect their ability to ambulate. All participants pro-
vided their informed consent to the experimental protocol, approved by the University
of Michigan Institutional Review Board (HUM00096819).
4.2.2 Experimental Protocol
Participants walked at their comfortable speed in a straight line over an 8 m walk-
way five times at self-selected speed. The average walking speed and cadence across
these trials was the in-lab capacity measure. Participants were then given two activ-
ity monitors (Actigraph GT9X Link, ActiGraph) and a Global Positioning System
(GPS) enabled smartphone (if they did not own one) to carry with them for a two-
week period (Fig. 4.1). One activity monitor was attached to the top of the shoe via
a small pouch. This monitor collected both accelerometer and gyroscope (IMU) data
at 100 Hz. A second monitor attached to the ankle of controls or prosthetic pylon
for individuals with amputation collected accelerometer (ACC) data at 30 Hz. Loca-
tion was monitored using the GPS tracking software Ethica (Ethica Data, Ontario,
Canada) or MapMyRun (Under Armour, Baltimore, MD).
4.2.3 Data Analysis
We defined non-sedentary bouts of activity using the ACC signal and ActiLife
software (ActiGraph, Pensacola, FL) as any period of activity with greater than 30
counts per minute (cpm) which lasted at least 1 minute [143]. This definition was
chosen as it had been previously used in people with lower limb amputation, who are
less active than healthy adults. ActiLife software calculated the total number of steps
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per day from the ACC signal as double the single leg stride count.
We first excluded any GPS data points given a low accuracy rating by Ethica.
For each observed bout from the accelerometer, we calculated the midpoint between
the bout’s start and end times (tmid, Fig. 4.2). The closest GPS time point to tmid
was denoted as tbest. The difference in time, tdiff, between tmid and tbest was used to
assess whether there was sufficient overlap of the ACC and GPS data (Fig. 4.2A).
Participant-specific perimeters established the boundaries of the home. These were
based on type of location (urban, suburban, and rural), sensor noise and resolution
around the home. From this, we designated bouts as ”at home” or ”away from home”
(Fig. 4.2B). If tdiff was less than 5 minutes, we used the GPS point at tbest to calculate
the distance between their location at that time and their home. If tdiff was between 5
minutes and 12 hours (Fig. 4.2C), we then checked if tbest was within the range of the
bout’s start and end times (Fig. 4.2D). If it fell within this bout, we determined tadj
as the chronologically adjacent GPS point, such that tmid was between tbest and tadj in
time. If the distance between these two GPS points was within the acceptable noise
based on participant-specific parameters (Fig. 4.2E), the person was assumed to have
stayed at the same general location and the GPS point at tbest was used to make the
at-home/away designation. For bouts that did not sufficiently overlap in time with
any GPS data point (i.e. tdiff >12 hr), or if the participant’s location change between
two consecutive GPS points was greater than the acceptable noise, we marked the
location as unknown.
Finally, we used IMU data to estimate the position of the prosthetic foot, in
order to calculate stride-by-stride cadence and walking speed. For each bout of non-
sedentary activity, the position and orientation of the foot were calculated using
pedestrian dead reckoning algorithms previously described in [109, 122]. Briefly, we
first identified a quiet period preceding the bout of movement using the gyroscope
signal. During this period, we oriented the IMU to the global reference frame and
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normalized the acceleration signal to gravity. We then integrated the acceleration
signal twice to calculate the trajectory of the foot. In order to reduce the error due
to signal drift, we applied zero velocity updates (ZUPT) at every foot-flat phase.
These phases were identified as periods when the gyroscope and gravity-normalized
acceleration magnitudes were close to zero (ω <30 ◦/s; α <1 m/s2). This process
corrected for erroneous velocities observed during each foot-flat phase by assuming
no slip between the foot and the ground. Next, we detected heel strikes by identifying
peaks in the vertical acceleration signal (minimum peak value of 6 G and a minimum
period of 500 ms between each peak). Heel strikes segmented the bouts of movement
into walking strides. We then used a rule-based algorithm to identify straight-line
walking strides (Fig. 4.3). We identified valid walking strides as those that had
horizontal position displacements between 0.5 m and 2 m and lasted less than 3.5 s.
We excluded any steps taken on stairs by eliminating any strides where the vertical
displacement of the foot between consecutive heel strikes exceeded the standard stair
height of 0.178 m [53].
We quantified the distribution of walking speeds and cadences taken during daily
life using a probability density function. To quantify cadence variability, we calculated
the variance of the cadence distribution. Additionally, we calculated the skew of each












where x is the sample mean, xi is each data point, and n is the sample size.
Assuming a unimodal distribution, a positive skew represents a distribution with a
mode that is lower than the mean, i.e., a long tail of values greater than the mean.
Conversely, a negative skew indicates the opposite, with a long tail of values less than
the median. A skew magnitude between 0.5 and 1 indicate a moderate skew, while
those less than 0.5 indicate an approximately symmetric distribution.
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Figure 4.2: Flowchart: syncing steps with location data
Determination of the location of non-sedentary bouts and the associated step
counts.
4.2.4 Statistical Analysis
We excluded any day with insufficient wear time (i.e., <6 hours). Because partici-
pants had varying amounts of valid sensor data, we bootstrapped each data set before
calculating the mean. For a data set with n elements, we sampled n elements with
replacement, then took the mean of the resampled set. This process was repeated
10,000 times. The bootstrapped mean was the mean of all 10,000 resampled means
[123].
We first compared the steps per day and steps per bout measured by the ACC
between groups (LLA/CON) using independent samples t-tests. The bootstrapped
mean cadence, walking speed, and stride length during daily life were calculated from
IMU data for all straight-line walking strides and compared between groups using
t-tests. We then compared the variance and skew of the distributions of cadence
and walking speed between groups using t-tests. Differences between average ca-
dence and walking speed measured in the lab and the average of those measured
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Figure 4.3: Flowchart: valid walking stride criteria
Rule-based algorithm for determination of valid level-ground walking strides.
Minimum detectable walking speed is 0.142 m/s, which encompasses common
walking speeds by limited and unlimited community ambulators [45]
during daily life were explored using a two-factor mixed measures ANOVA, where
group (LLA/CON) was a between subjects factor and setting (in-lab/daily life) was
a within subject factor. After excluding activity data without a successful location
designation, we compared straight-line walking cadence and walking speed between
locations (Home/Away) and groups (LLA/CON) using a series of mixed measures
ANOVAs. All statistics were performed in SPSS v24 (IBM, Armonk, NY) with a
significance level of 0.05.
4.3 Results
We collected an average of 7.59 days of IMU data, 16.9 days of ACC data, and
13.9 days of GPS data from the LLA group. An average of 2.3 days of ACC data
per person were excluded when calculating daily step counts due to insufficient wear
time. The LLA group took an average of 4252 ± 2558 steps per day, with half on the
instrumented leg. The IMU data yielded a total of 8710 ± 7440 straight-line walking
strides of the instrumented leg, over the collection period, per person (Table 4.1). Of
these, 2670 ± 2500 strides detected as at home and 4250 ± 4520 strides away from
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Figure 4.4: Cadence in daily life
A. Split violin plot of the probability density functions of cadence distributions for
the group with lower limb amputation (LLA) and control (CON) group (top) and
between strides taken at home and away (bottom). Raw distributions were
smoothed using a kernel smoothing function (ksdensity) in MATLAB for
visualization. Shaded regions are averaged distributions, solid horizontal lines are
the group means, and dashed horizontal lines are the group means for in-lab
measures. B. Variance of cadence distribution for each group (top) and for strides
taken at home and away (bottom). C. Skew of the cadence distribution for each
group (top) and for strides taken at home and away (bottom). K2 (4), K3 (◦), K4
(×). ∗significant differences (p < 0.05) between in-lab and daily life.
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Table 4.2: Group comparisons of activity during daily life
home. 11 participants in the LLA group completed the in-lab portion of the study
and were analyzed for the in-lab/daily life comparison. One participant (LLA 01)
did not record any IMU walking strides while at home and was therefore excluded
from location comparisons for cadence and walking speed (nLLA = 16 for location
comparisons).
Control participants had an average of 14.0 days of IMU data, 17.3 days of ACC
data, and 16.7 days of GPS data. We excluded an average of 1.9 days of ACC data
due to insufficient wear time. The control group took 7774 ± 1448 steps per day,
which was significantly greater than that of the LLA group (p <0.001). The control
group took a total of 36300 ± 18000 straight-line walking strides, per person, over the
collection period (Table 4.1). Of these, 7210 ± 8460 strides were taken at home and
23100 ± 10700 strides were away from home. While we did not match control and
LLA participants, there were no differences in age (p = 0.485), height (p = 0.598),
or BMI (p = 0.061) between the groups. Data collection occurred through different
seasons (Table 4.1).
4.3.1 Cadence
The control and LLA groups both walked at similar cadences during their daily
lives, at 58.3 strides/min for controls and 58.1 strides/min for the LLA group (Fig.
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4.4A). Both groups walked at a lower cadence (57.2 strides/min for controls and 49.4
strides/min for the LLA group) during the in-lab session (p = 0.041, Table 3). While
there were no group differences in cadence (p = 0.070), the LLA group had a much
larger within-group range compared to the control group (Fig. 4.4B). Both groups’
cadence distributions were positively skewed, indicating a greater concentration of
cadence values below the mean (Fig. 4.4C). There were no significant differences be-
tween the groups. While all control participants had a positive skew, four participants
in the LLA group either had a negative skew or a symmetric distribution. There were
no differences in cadence, cadence variance, or cadence skew between steps taken in
and out of the home (Table 4.3).
4.3.2 Walking Speed
During daily life, the control group walked faster than the LLA group by an av-
erage of 0.21 m/s (p = 0.005; Table 4.2 Fig. 4.5A). Both groups also walked faster
during the in-lab session than in daily life (p <0.001). This difference was larger
for the LLA group (0.2 m/s vs 0.15 m/s). Walking speed variance was not differ-
ent between the two groups (Fig. 4.5B). Both groups’ walking speed distributions
were symmetric, though the LLA speed distribution was significantly more positively
skewed than that of the control group. This indicates that a larger number of walking
Table 4.3: Comparison of activity taken in and away from home
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strides were taken at slower speeds for the LLA group (p = 0.048; Fig. 4.5C). Two
participants in the LLA group had skew values greater than 1, while all other par-
ticipants either had moderate or symmetric skew values. Both groups walked faster
when away from home (p = 0.014, Table 4.3). Location had no effect on the variance
of walking speeds. Both groups’ walking speed distributions were more symmetric
when away from home (p = 0.010).
4.3.3 Walking Speed vs. Stride Length
Because there were group differences in walking speed but not in cadence, we
conjectured there would be differences in stride length. As expected, individuals
with LLA had a shorter stride length (p = 0.007; Table 4.2). Similarly, as there
was a location effect on walking speed but not on cadence, changes in stride length
facilitated this change in walking speed, as stride length increased when away from
home (p = 0.006; Table 4.3).
4.4 Discussion
Recent studies have shown the effectiveness of using wearable sensors to under-
stand ambulation characteristics of individuals with LLA during daily life [88, 68, 75].
The purpose of this study was to fuse IMU with GPS data during daily life and ex-
plore its clinical viability of characterizing functional mobility. The findings can be
summarized as follows: (1) both healthy controls and individuals with LLA walked
slower during their daily lives compared to their in-lab measures (2) cadence variance
during daily life was not different between the control and LLA groups, and (3) both
groups walked significantly faster outside of the home.
There were no differences in average cadence, cadence variance, or skew between
steps taken at home and those away from the home. On the other hand, location
had a significant effect on walking speed and walking speed skew. Controls increased
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Figure 4.5: Walking speed in daily life
A. Split violin plot of the probability density functions of walking speed
distributions for the group with lower limb amputation (LLA) and control (CON)
group (top) and between strides taken at home and away (bottom). Raw
distributions were smoothed using a kernel smoothing function (ksdensity) in
MATLAB for visualization. Shaded regions are averaged distributions, solid
horizontal lines are the group means, and dashed horizontal lines are the group
means for in-lab measures. B. Variance of walking speed distribution for each group
(top) and for strides taken at home and away (bottom). C. Skew of the walking
speed distribution for each group (top) and for strides taken at home and away
(bottom). K2 (4), K3 (◦), K4 (×). ∗significant differences (p < 0.05) between
in-lab and daily life. ∗∗significant differences (p < 0.05) between home and away.
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the walking speed from 1.12 m/s in the home to 1.23 m/s out of the home, while the
LLA group increased from 0.88 to 1.04 m/s. While both groups had increased speeds,
the average speed for the LLA group was still less than that required for traversing
crosswalks [45, 35]. Lastly, both groups increased their stride lengths (by 0.12 m/s
for controls, 0.15 m/s for LLA) when away from home to facilitate the faster walking
speeds. We do not know enough about the external factors that brought about
these changes in gait to claim the relative importance of cadence, walking speed,
or stride length, and the majority of relevant studies have only reported cadence
and/or walking speed during daily life [68, 4, 75]. However, measuring the relationship
between the three gait parameters and how they change may provide insight on gait
adaptability and mobility. To do this, we used pedestrian dead reckoning algorithms
to calculate stride-by-stride values of stride length, cadence, and walking speed during
daily life.
Both groups had greater cadence and walking speed when measured in-lab com-
pared to their performance measures from daily life (Table 4.2). The differences in
walking speed (0.15 m/s for controls and 0.2 m/s for LLA) were greater than the min-
imal clinically important difference (MCID) or minimal detectable change (MDC)
in walking speed (between 0.1 and 0.2 m/s for individuals with impaired mobility
[13, 97]. Similarly, Urbanek et al. found that older adults had a 20 step/min greater
cadence in the lab compared to daily life [152]. They speculated that participants
being alert and focused during the experiment led to them “over performing” in the
lab [152]. In daily life, people have many additional things to focus their attention on
beyond simply walking. As such, everyday walking speed is more similar to dual-task
walking done in-lab compared to normal walking in the lab [65].
Walking speed is an important indicator of health and is strongly associated with
community ambulation [117, 45, 132, 35]. Previous studies have established speed cut-
offs to classify household (<0.4 m/s), limited community (0.4 — 0.8 m/s), normal
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community (0.8 — 1.2 m/s), and active community ambulators, or those who can
comfortably cross the street (>1.2 m/s) [5, 35]. From a clinical perspective, the
distinction between a community- and household ambulator is quite simply dependent
on whether the patient walked outside their home. Further, if their average speed
exceeded 0.8 m/s away from home (14 of 16 LLAs, all controls), they could safely
be classified as a normal community ambulator. Beyond these distinctions, however,
it is unclear if we can conclusively classify levels of community ambulation using
walking speeds during daily life. Moreover, we cannot comment on the relative validity
of the settings in which the walking speed is measured (in-lab vs daily life). It is
nonetheless important to recognize that walking speed differed at different settings
of measurement and that measurements during daily life can offer a perspective that
in-lab measurements do not.
The LLA group walked significantly slower than the control group during daily life.
This result agreed with numerous previous studies that have measured preferred walk-
ing speeds in laboratory/clinic settings [74, 11, 107, 155] as well as average walking
speeds in the everyday environment [68]. We expanded upon prior work by character-
izing the distribution of walking speeds for steps taken in daily life. While the LLA
and Control groups had similar variance in speeds, the LLA group had a more posi-
tively skewed distribution of speeds. This indicates that LLA and control participants
had similar ranges of speeds throughout the day, but that the LLA group took more
of their steps at slower speeds. There are several possible reasons why the LLA group
had a greater concentration of strides at lower speeds compared to controls. First,
the LLA group took a greater proportion of their walking strides at home compared
to controls (Table 4.3) and walking bouts at home may consist of lower-speed (Fig.
4.5A, bottom) short-distance trips (e.g. bedroom to bathroom). Another potential
explanation is that LLAs walk faster only when required (e.g. cross the street, catch
the bus), but prefer to walk at slower speeds. However, these possibilities are specu-
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lative as activity data can only quantify what the person did in their daily life, not
why they chose to do it.
We also quantified cadence variability as it is a K-level descriptor and thought to
represent adaptability to different circumstances and environments [59]. The control
and LLA groups had similar cadence variance. This is perhaps unsurprising, as a
majority of the LLA participants were K3 or higher, and thus should have ”the
ability or potential for ambulation with variable cadence” [41]. However, there was
a great deal of variability within the LLA group. The average cadence variance in
strides2/min2 was 522 for the K2 group (n = 2), 522 for the K3 group (n = 13)
and 285 for the K4 group (n = 2), while the control group averaged 318. While
these results seem to indicate that K-levels could not be differentiated based on daily
cadence variance alone, the sample sizes are small. In the current Medicare system,
the ability for variable cadence is associated with higher functionality. Our results
suggest that those with higher function actually walk at a narrower range of cadences
throughout daily life. It is important to recognize that while K-levels are aimed
at assessing capacity or potential for mobility, our approach measured the actual
cadence variability during daily life. During in-clinic assessments, prosthetists may
instruct patients to walk at different speeds to visually assess cadence variability. Our
approach of examining cadence values from steps taken during daily life utilized a rule-
based algorithm (Fig. 4.3) that could have eliminated walking steps where cadence
variability was high, such as sharp turns, side steps, or small steps in crowded or
tight areas. Ultimately, people may not vary their cadence for a significant portion
of straight-line walking during daily life, not because they are unable to, but because
they are not required to. Therefore, future work with a larger and more heterogeneous
cohort is needed to determine the relationship between everyday cadence variability
and functional mobility.
In this study, we were able to specifically explore how characteristics of walking
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differ in and out of the home. There are several reasons to suspect that these might be
different. Walking may be affected by external requirements, environmental barriers
(e.g. curbs, slopes, or uneven terrain), space limitations, or other factors that may
be different in and out of the home. The control group took a greater number of
straight-line walking strides when away from home, whereas the LLA group’s number
of strides did not change by location (Table 4.3). This may suggest individuals with
LLA do not take more steps away from the home due to environmental constraints or
lower confidence in their mobility. Important to note, however, is that the IMU sensor
was worn on the shoe and many control participants noted that they did not wear
their shoes (and IMU) at home. To investigate this issue, we compared the end-of-day
doff times (based on wear time analysis) between the IMU and ACC using a t-test.
On average, control participants doffed the IMU an hour and a half before they doffed
the ACC, while the difference in doff time for the LLA group was approximately 30
minutes, though this was a non-significant trend (p = 0.07). Additionally, people do
not tend to take many steps at the end of the day, so this issue may not have a large
effect on total number of strides at home.
While it may be of interest to know specifically where people perform activities,
there are several issues that may limit the feasibility of this approach. These issues
mainly stemmed from the use of GPS data taken from smart phones. Most smart
phones are not dedicated GPS collection devices, so their GPS sampling rate and
accuracy can be highly variable and dependent on factors such as location (i.e. GPS
signal tends to be less accurate in buildings as well as more rural areas) and hardware
type (i.e. different phones have different signal strengths). Additionally, the phones
had to be charged nightly, which participants often forgot to do according to their
self-report. This resulted in missing GPS data. Gaps in GPS data were examined
through a rule-based algorithm (Fig. 4.2) that found the best GPS match for activity
data. Unfortunately, there was still a non-negligible amount of activity data that
73
could not be properly synchronized with location data. This data was excluded from
location (home vs away) analysis. Given the sparsity of the GPS data and the fact
that many of our participants were either retired or did not have routine schedules, we
were unable to distinguish activity location beyond ”home” and ”away from home.”
While we attempted to obtain more context on where participants were throughout
the day via a self-recorded activity log, these were often returned empty or lacking
information regarding type of activity or where it took place. The feasibility of
location determination may be improved by emerging technology for dedicated GPS
devices, which continues to improve in terms of sampling rate and battery life.
There are several other findings regarding the feasibility of our approach. While
we aimed to collect data for a two-week period, the actual number of days was highly
variable across participants. Some participants did not charge the IMU at night.
When the battery dies on these sensors, they must be re-initialized using the Ac-
tiLife software. We made every effort to replace monitors, however, many of these
participants ended the collection period with incomplete sets of data. Using activity
monitors that do not require re-initialization for collection after a dead battery may
improve the completeness of recorded data. Additionally, while the groups had simi-
lar age, height, and BMI, there was no way to control for other factors that may have
influenced participant behavior. These factors include weather, living environments,
social support systems, working environments and associated travel requirements,
personality, among others. Weather conditions may influence the amount of physical
activity away from home, particularly in the colder Michigan climate. A snowy day
with slippery walkways during winter may affect walking speed or stride length away
from home differently to a similarly cold winter day with no snow or ice. We collected
both groups across a range of seasons such that each group would be similarly affected
by these climate conditions. While logistically difficult, future work could initialize
activity monitors for patient and control groups on the same day to mitigate weather
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effects.
Our approach of measuring functional mobility from walking during daily life has
shown that it is feasible to measure the daily performance of a person with lower
limb amputation in a way that provides useful information to the providers of clinical
care. Using wearable sensors, we were able to record a large number of straight-line
walking strides, on the order of thousands of strides over a two-week collection pe-
riod. Approximately 83% of all strides had a location designation (at home or away),
which added location context to a large volume of collected data. In addition, we
were able to extend on prior work by calculating walking speed for each stride us-
ing IMUs. This approach has the potential to aid clinicians during the prescription
of prosthetic components by accompanying clinicians’ in-clinic assessments of func-
tional capacity with measures of physical performance during daily life. Claims for
more advanced components can be stronger if they are substantiated by walking data
spanning multiple days of unconstrained observation rather than in-clinic assessments
alone. For example, if the amputee exhibits higher walking speeds from a large num-
ber of steps away from home, they will likely experience many environmental barriers
such as stairs and ramps, which would justify the need for more sophisticated pros-
thetic componentry. Additionally, this technology could be used post-prescription to
evaluate the effectiveness of the prosthetic intervention in the patient’s routine envi-
ronment. Pre-prescription measurements could establish a baseline measurement of
activity and establish goals with the patient. Post-prescription measurements could
then help assess the achievement of these goals. Improvements toward clinical feasi-
bility would involve further categorizing the data into different contexts for clinical
interpretation. The ability to categorize walking strides into different tasks or con-
texts (e.g. climbing stairs, walking up a curb, navigating ramps or tight spaces) was
not demonstrated in this paper, but would give clinicians more specific information
on patient mobility during daily life.
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4.5 Conclusion
This study presented a novel approach to quantifying performance of functional
mobility during everyday life for healthy adults and individuals with LLA. Our results
demonstrated the importance in measuring walking speed performance during daily
life, in addition to measuring its capacity in clinic or laboratory settings. Additional
research is needed to understand the clinical relevance of cadence variation during
daily life. The presented approach is a step toward developing objective methods
to help inform clinicians about functional mobility in lower-limb prosthesis users.




The Influence of Powered Prostheses on User
Perspectives, Metabolics, and Activity: A
Randomized Crossover Trial
5.1 Introduction
People with transtibial amputations (TTA) walk with greater asymmetry, using
more metabolic energy, and prefer to walk more slowly than people without ampu-
tation [155]. These factors may contribute to their decreased physical activity level
[92]. In particular, people with TTA have lower daily step counts [140] and walk for
shorter durations at a time, compared to people without amputation [88, 113]. This
deficit is important to address, as physical inactivity is related to lower quality of
life [116] and can lead to secondary comorbidities such as obesity and cardiovascular
disease [61].
Powered ankle-foot systems, such as the BiOM (now Ottobock Empower, Duder-
stadt, Germany) aim to reduce gait asymmetries and metabolic effort by providing
active “ankle” power during the push-off phase of gait [7]. Prior studies have found
that the powered prosthesis enabled people with TTA to use less metabolic effort to
walk over level-ground [63, 130], while others found no differences on level-ground
[49] or on slopes [102]. Similarly, while some studies found that participants walked
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at faster speeds with the powered prosthesis over a loose rock surface [50] and on
level surfaces [63, 38], a more recent study found no differences in self-selected walk-
ing speed [49]. The participant cohort in the latter study differed from earlier ones
as participants were older and potentially less physically active. Further, the study
found that people designated as the highest Medicare functional classification level
(K4) had reduced metabolic effort with the powered prosthesis, while those at a lower
level (K3) did not [49]. This suggests that the benefits of prosthetic ankle power may
depend on characteristics of the user, as the Medicare Functional Classification Level,
or K-level, is a system that describes the rehabilitation potential of a person with
lower-limb amputation [41].
While mixed, prior studies provide some evidence that prosthetic ankle power can
be effectively incorporated into the user’s biomechanics to reduce their effort. It is
unclear, however, whether this translates to changes in physical activity in daily life.
Prior work has exclusively characterized measures of capacity, or what one is capable
of in a standardized or optimal environment. According to the International Clas-
sification of Functioning, Disability and Health (ICF), evaluating performance, i.e.,
what one does in their actual environment, is also an important component of charac-
terizing functionality [114]. Because the patient’s surroundings can play a large role
in the accessibility to physical activity, it is imperative that evaluations of physical
activity are made in the patient’s everyday environment. As such, a growing number
of studies have employed community-based activity monitoring to evaluate prosthetic
interventions, to provide clinicians with more comprehensive characterizations of the
patient’s functional mobility [20]. The ICF also recommends that to properly mea-
sure improvements in health, psychological and social aspects of health should also
be collected, which may heavily impact everyday performance. Overall, there are
numerous factors that can contribute to or limit a patient’s performance in everyday
life. Evaluating changes to those factors is a necessary step in moving toward a more
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comprehensive evaluation of powered prostheses.
Examining patient perception is one way to track changes to psychosocial factors
that may affect mobility. While metabolic effort undoubtedly represents valuable in-
formation, it may not necessarily correlate to the patient’s perception of exertion [139].
Further, a previous study found no statistical difference in participants’ Prosthetic
Evaluation Questionnaire scores between using unpowered and powered prostheses
[38], whereas the same cohort reduced their metabolic costs with the powered pros-
thesis [130]. Given these differences, it is important to explore both perception of
effort and measures of effort as is it unclear which relates more to a person’s physical
activity. For example, if a device is perceived to be easier to walk with, even if it
does not objectively reduce metabolic effort, this may alleviate conscious barriers to
physical activity and enable an increase in the amount of physical activity.
In this study, we conducted a randomized crossover trial comparing the use of
unpowered and powered prostheses in people with TTA, after one week of unsuper-
vised device acclimation. Our primary goal was to quantify differences in metabolic
cost, the volume (step count) and characteristics (walking speed) of everyday walk-
ing, as well as patient perceptions of their mobility and quality of life when wearing
each prosthesis. We hypothesized that there would be differences in metabolic cost,
step count, and walking speed when using the powered prosthesis, compared to the
unpowered prosthesis. Based on prior work, we also hypothesized that participants
would not perceive a change in mobility with the powered prosthesis. A secondary
aim of this work was to explore the relationship between patient perceptions and




People with unilateral transtibial amputations (TTA) were recruited through clin-
ical referral from the University of Michigan Orthotics and Prosthetics Center and
through flyers and postings on https://umhealthresearch.org and https://clinicaltrials.gov
(NCT02828982). Inclusion criteria included: aged 21 years or older, unilateral TTA,
and prosthetic use for at least six months. Potential participants were excluded if
they had a history of cardiovascular disease, or orthopedic or neurological disorders
to their intact limb, or were unable to walk independently for 10 minutes at a time.
Participants’ K-levels were obtained from their physician. We initially recruited older
community ambulators (K3) who may be less physically active than in previous works
[130, 38], as benefits of the powered prosthesis were less clear for this population
[49]. However, due to recruiting difficulties, we later included more active community
ambulators (K4). All participants provided their written informed consent prior to
participation.
5.2.2 Experimental Protocol
This study utilized a cross-over design where participants were randomly assigned
to perform testing first with their prescribed, unpowered prosthesis or with a powered
prosthesis. For the powered condition, a certified prosthetist fit participants with
a BiOM T2 powered prosthesis (BionX Medical Technologies Inc., Bedford, MA,
USA) and tuned the device according to procedures described in Gardinier et al.
[49]. They were then given one week to acclimate to the device at home and did
not receive any device-specific training. Participants returned to the clinic if they
needed any adjustments to their prosthetic settings or alignment. After any change,
participants were given another week to acclimate. Only two participants (S03, S06)
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required readjustments. Participants acclimated freely at home and did not receive
any directed training with the powered prosthesis. For the unpowered condition,
participants needed to be stable in their prescribed prosthesis (no adjustments) for a
period of at least one month prior to collection.
After the acclimation period, participants were given two activity monitors (Acti-
Graph GT9X Link, ActiGraph, Pensacola, FL, USA) and a global positioning system
(GPS) enabled smartphone for a two-week period. One activity monitor was mounted
on top of the prosthetic foot and collected accelerometer and gyroscope (IMU) data
at 100 Hz, while the other (ACC) was attached to the lateral side of the prosthetic
pylon and collected accelerometer data at 30 Hz. The placement for the ACC was
chosen for its high test-retest reliability for step counts [16], while the IMU was place
on top of the foot to ensure minimum movement during foot-flat [122]. GPS data
were collected using either Ethica (Ethica Data, Ontario, Canada) or MapMyRun
(Under Armour, Baltimore, MD). Participants were given an activity log to record
their activity during the collection.
Following acclimation and activity data collection (≥ 3 weeks), participants came
to the lab for metabolic testing and to complete questionnaires assessing their over-
all health and quality of life. Participants were instructed to fast for at least four
hours prior to metabolic testing. We used a portable metabolic system (Cosmed
K4b2, Rome, Italy) to measure participants’ oxygen consumption and carbon diox-
ide production. We first measured baseline metabolic costs as participants rested in
a seated position for at least 10 minutes. We then measured metabolic costs while
participants walked on a treadmill at a controlled speed based on leg length [54].
Participants walked for a minimum of three minutes after they achieved steady-state
oxygen consumption, characterized by a visible plateau [30]. Once participants felt
rested, we measured their self-selected walking speed by having them walk over a
straight 8 m walkway, ten times.
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Participants completed the Prosthetic Evaluation Questionnaire (PEQ) and Short
Form (SF)-36 after each prosthetic condition and a Prosthetic Preference question-
naire at the end of the study. The PEQ consists of 82 questions that describe the
function of a lower-limb prosthesis and assesses prosthesis-related quality of life [91].
The questionnaire is divided into ten functional scales, addressing four major domains:
prosthetic function, mobility, psychosocial experience, and well-being. Participant’s
quality of life was assessed using the Short Form (SF)-36 general health questionnaire,
which provides eight component scores and Physical and Mental component scores.
The Prosthetic Preference Questionnaire consisted of a single question where partic-
ipants were asked to indicate which device they preferred on a 100 mm visual analog
scale (VAS) from their unpowered device (0) to the powered ankle (100). Finally,
using a semi-structured questionnaire, we asked participants for subjective feedback
about their likes and dislikes and what if anything felt easier and/or harder with the
powered prosthesis. If not mentioned, we then specifically asked about the ease of
walking faster, longer, and on different types of terrain (e.g. uneven ground, stairs,
slopes).
5.2.3 Data Analysis
We first verified that the last three minutes of breath measurements were at a
steady state by confirming a respiratory exchange ratio between 0.7 and 1.0. Using
the recorded steady-state oxygen consumption and carbon dioxide production rates,
we estimated energy expenditure using the Brockway equation [17]. To generalize
energy expenditure across participants, we calculated a dimensionless metabolic cost
of transport (COT) by normalizing energy expenditure by participant weight and
walking speed [33].
The accelerometer and IMU were programmed to begin data collection on the day
following meeting with study personnel at 12 am, to avoid partial day collections. The
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accelerometer collected data until the battery died, which was typically around 12
days. We excluded data from days in which wear time was < 6 hours [85], which
may be due to participants not wearing the prosthesis or leaving the accelerometer
on the charger for the day. ActiLife software (ActiGraph, Pensacola, FL, USA)
calculated daily step counts as double the single leg stride count from the pylon-
mounted accelerometer. Periods of non-sedentary activity were defined as any period
of activity greater than 30 counts per minute epoch [143]. Such a low threshold
includes small movements and detects even a single strides as ‘non-sedentary activity.’
We then separated steps that occurred during the active period as ‘at home’ and ‘away
from home’ using the time matched GPS data [85].
Because the pylon-mounted accelerometer recorded data at a low sampling rate (30
Hz), battery life lasted approximately 12 days, and we did not instruct participants
to recharge the accelerometer overnight. IMU battery life was typically only 24 hours,
due to the higher sampling rate. As such, participants were instructed to charge the
IMU every night. Because we did not derive daily averages from the IMU, we did
not exclude data from days with low wear time. To calculate stride-by-stride walking
speed, we first calculated the position trajectory of the prosthesis-mounted IMU using
a strapdown inertial navigation algorithm [110]. Briefly, the algorithm integrated the
acceleration signal twice to calculate a position trajectory and applied zero velocity
updates at every foot-flat to reduce drift error [122]. Strides were segmented with heel
strikes, detected using the acceleration signal (vertical peak acceleration > 6 G and
500 ms between peaks) and velocity estimates (5 ms-window mean vertical velocity <
0). We then used this data to calculate walking speed according to methods described
in Kim et al. [85].
For the PEQ and SF-36, we averaged scores for questions within each domain or
sub-scale, omitting any blank entries. Values were only included where participants
answered more than 50% of the questions in that domain [91].
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5.2.4 Statistical Analysis
To mitigate the effects of varying amounts of accelerometer and IMU data collected
by each participant, we calculated the bootstrapped mean for each outcome measure
taken during everyday activity (step counts, walking speed). For example, from a
data set with size n, we sampled n elements with replacement, took the mean of the
resampled set, and repeated this process 1000 times. The mean of all 1000 resampled
means is the bootstrapped mean [123], which was used for analysis. Self-selected
walking speed in the lab was the average of 10 trials. We tested for differences
in COT, daily step count, daily step count away from home, walking speed (in-lab
and in daily life), PEQ (by sub-scale), and SF-36 (by sub-scale and physical and
mental components) between the two prostheses (unpowered, powered) using a series
of paired t-tests. We assessed whether prosthetic preference was significantly different
from 50 (no preference) using a one sample t-test. Significance was set to p < 0.05
for all comparisons. Given the small sample size, we calculated the effect sizes for all












(SD2Powered(nPowered − 1)) + (SD2Unpowered(nUnpowered − 1))
nPowered + nUnpowered − 2
where Mx is the mean of group x, SDpooled is the pooled standard deviation,
N is the sample size, SDx is the standard deviation within group x, and nx is the
sample size of group x [36]. Effect sizes are interpreted as being small for 0.2 ≤
g ≤ 0.5, medium for 0.5 ≤ g ≤ 0.8, and large for g ≥ 0.8 [23]. We also explored
the relationships between COT, activity during daily life, prosthetic preference, and
patient perception using Pearson correlations. We noted comparisons with medium
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effect sizes (|g| ≥ 0.5) in the results section.
5.3 Results
5.3.1 Participant Details
A total of 31 patients were contacted about the study (Figure 5.1). Eight declined
to participate citing the time commitment or their lack of interest in new prostheses,
while three others did not respond. Another eight were deemed ineligible. The
remaining 12 individuals were randomly allocated to a prosthetic testing order (Table
5.1). S09 dropped out before completing the study due to an unrelated medical
condition. S10 was assigned to the powered prosthesis first, acclimated to the device
and was provided activity monitors. During this time, he developed a wound on his
residual limb and subsequently dropped out of the study. Ten males (52.6 ± 11.3
years old) completed the study. Nine were classified as K3 and one was classified as
K4 on the Medicare K-level.
5.3.2 Metabolic Cost
There were no differences between the fixed treadmill speed (1.20 ± 0.07 m/s)
and self-selected walking speeds with the unpowered (1.16 ± 0.16 m/s; p = 0.435) or
powered prostheses (1.21 ± 0.12 m/s; p = 0.794). S03 was not able to achieve steady-
state energetic expenditure on a treadmill. For the remaining participants, there was
no group difference in metabolic cost of transport (COT) between prostheses (n =
9; p = 0.585, g = -0.150), but there was variability across participants. While six
participants had lower COT with the powered prosthesis, only two participants had
reductions greater than the between-day minimal detectable change of 0.051 J/Nm
[30].
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Figure 5.1: Consort flow diagram for recruitment, enrollment, and analysis
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Table 5.1: Participant demographics
Table 5.2: Step count and walking speed in-lab and in daily life (mean ± SD)
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Figure 5.2: Overall step count and step count away from home
A. Daily step count using the unpowered (red) and powered (blue) prostheses.
Dashed horizontal line represents the recommended 10,000 steps per day. B. Daily
step count away from home using the unpowered (red) and powered (blue)
prostheses. Gray x’s and lines represent individual participant trends.
5.3.3 Activity Data
There were no differences in the bootstrapped daily step count (p = 0.995, g = -
0.001; Figure 5.2A) or daily step count away from home (p = 0.452, g = -0.248; Figure
5.2B) between prostheses (Table 5.2). While step counts varied across participants,
none achieved the recommended 10,000 steps per day [150].
There was no difference between prostheses in self-selected walking speeds in the
lab (p = 0.145, g = 0.310; Figure 5.3A). Though S05 and S06 completed the study,
due to a sensor malfunction, the activity monitor did not record sufficient IMU data
with the powered prosthesis. These participants were therefore excluded from all
daily-life walking speed comparisons. There was no difference between prostheses in
walking speeds during daily life (n = 8; p = 0.226, g = -0.158; Figure 5.3B).
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Figure 5.3: Walking speed in-lab and in daily life
A. Self-selected walking speeds measured in the lab for participants using the
unpowered (red) and powered (blue) prostheses. Gray x’s and lines represent
individual participant trends. B. Split violin plot of the probability density
functions of walking speed distributions of walking strides taken in daily life. To
visualize, raw distributions were smoothed using the ksdensity kernel smoothing
function in MATLAB. Shared regions are averaged distributions and solid
horizontal lines are the group means.
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5.3.4 Questionnaires
In the Prosthetic Evaluation Questionnaire (PEQ), participants reported signifi-
cantly less social burden with the powered prosthesis, compared to that of the unpow-
ered prosthesis (p = 0.043, g = 0.268; Figure 5.4). There were also non-significant,
medium- and large-sized effects in the mobility and frustration sub-scales where par-
ticipants reported better mobility (p = 0.058, g = 0.682) and less frustration (p =
0.052, g = 0.506) with the powered prosthesis. For the Short Form (SF)-36 ques-
tionnaire, there were no differences in the physical (p = 0.480, g = -0.143) or mental
component scores (p = 0.370, g = 0.141), or any of the individual sub-scales (p ≥
0.080, |g| ≤ 0.408). While participants generally preferred the powered prosthesis
(prosthetic preference score = 64.1 ± 33.8; g = 0.598), this was not significantly
different from no preference(p = 0.132).
5.3.5 User Feedback
The open-ended user feedback was mixed across participants. One participant
reported that they liked that the BiOM “almost felt like a real ankle” while another
participant similarly commented that walking with the BiOM “felt more natural.” Six
participants disliked that the BiOM batteries die too soon, two said it was too bulky,
one said it was too noisy, one said it was too heavy, and one described the BiOM
as being too controlling and causing more phantom pain. Six participants felt that
they could walk faster with the BiOM, while four did not. Five participants felt they
could walk for longer when wearing the BiOM. Five participants found walking to be
easier : five found it easier to walk on slopes, six found it easier to walk upstairs, and
three found it easier to walk downstairs. In contrast, four found level-ground walking
harder : five found walking down stairs to be more difficult, four found uneven terrain
(specifically grass and snow) to be more difficult, two found driving more difficult and
one found it more difficult to stand from a chair. The remaining respondents did not
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Figure 5.4: Prosthetic comparisons in questionnaires and surveys
Changes in participant responses for the Prosthesis Evaluation Questionnaire, Short
Form-36 and Prosthetic Preference, by sub-scale. Significant differences (p < 0.05)
between prosthesis are indicated and bolded (*). Changes with a medium or large
effect size (g ≥ 0.5) are also indicated and bolded (†).
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notice a difference or did not perform that activity.
5.3.6 Correlations
Prosthetic preference was not correlated with changes in COT (r = -0.181, p =
0.667; Figure 5.5A), with changes in walking speed measured in-lab (r = -0.086, p =
0.814; Figure 5.5B), or with changes in walking speed in daily life (r = 0.070, p =
0.869; Figure 5.5C).
Changes in daily step count were not correlated with changes in COT (r = -0.074,
p = 0.849; Figure 5.6A), or perception of mobility when assessed with the PEQ
ambulation sub-scale (r = 0.324, p = 0.395; Figure 5.6B). There was a moderate
correlation between changes in step counts and the SF-36 physical functioning sub-
scale (r = 0.505, p = 0.137; Figure 5.6B). There were no relationships between changes
in step count away from home and the PEQ social burden sub-scale (r = 0.204, p =
0.628) or the SF-36 social functioning sub-scale (r = 0.120, p = 0.740; Figure 5.6C).
5.4 Discussion
Contrary to our hypothesis, we did not find differences between prostheses in
metabolic costs. Differences in metabolic cost between prostheses varied across par-
ticipants, however. Two participants reduced their metabolic effort by more than the
minimum detectable change (MDC) of 0.051 J/Nm, while two others increased their
metabolic cost more than this amount [19]. In our study, we measured metabolic costs
as participants walked at a fixed, leg length-based, speed. While metabolic results
may have been different if participants walked at their self-selected speed, potential
differences in our study were likely marginal. There were no differences between fixed
(1.20 ± 0.07 m/s) and self-selected walking speeds with the unpowered (1.16 ± 0.16
m/s; p = 0.435) or powered prostheses (1.21 ± 0.12 m/s; p = 0.794). Additionally,
in a previous study with a similar participant cohort, there were no metabolic dif-
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Figure 5.5: Relationships between prosthetic preference and other outcomes
A. Changes in prosthetic preference vs. changes in metabolic cost (∆COT). Dashed
lines indicate the minimal detectable change in COT. B. Changes in prosthetic
preference vs. changes in daily step count. C. Changes in prosthetic preference vs.
changes in walking speed in daily life.
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Figure 5.6: Relationships between step counts and other outcomes
A. Changes in metabolic cost (∆COT) vs. changes in daily step count. Data in the
second quadrant (highlighted in green) indicate lower metabolic cost and greater
step count with the powered prosthesis. B. Changes in the PEQ ambulation
sub-scale vs. changes in SF-36 physical functioning sub-scale scores (left) and
changes in daily step count (right). C. Changes in the PEQ social burden sub-scale
vs. changes in SF-36 social functioning sub-scale scores (left) and changes in daily
step count away from home (right). Data in the first quadrant (highlighted in
green) indicate greater scores and greater step count with the powered prosthesis.
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ferences between unpowered and powered prostheses in both fixed and self-selected
walking speeds [49]. Overall, these findings agree with one previous study [49], but
disagree with two others [63, 130]. There are two notable differences in these prior
works. In those studies that found a metabolic benefit, participants were young or
physically active and had time to adjust to the powered prosthesis (≥ 2 hours). The
study that did not find a benefit tested an older, less active cohort and only provided
a short time (∼ 15 min) for device accommodation. Here, we also tested a popula-
tion that was generally less active, but participants had a minimum of three weeks
of device use prior to metabolic testing. Further, two participants already owned the
BiOM and had been regularly using the device for at least 6 months. The two BiOM
owners had contrasting responses to the powered prosthesis in metabolic cost, step
count, and walking speed. While this may suggest that the lack of metabolic benefit
is more related to patient characteristics than accommodation time, it is also pos-
sible that less active individuals require even more accommodation or more focused
rehabilitation. Although there is no consensus on the time required to acclimate to
a prosthetic intervention [154], the accommodation provided here falls in line with
previous studies that found significant metabolic reductions after 1.5 weeks [159] and
21 days [57] of a prosthetic intervention. There is also no set training for adjusting to
a new prosthesis. This likely contributes to the variability in participant responses.
Our user feedback on learning to use the powered prosthesis also supports this idea
as some felt they learned “right away” while others said they “still haven’t figured
it out yet” (Appendix B.3). Additionally, while we ensured a minimum time period
for acclimation, we could not control for the actual amount of acclimation, as this
may depend on how much each participant used the prosthesis in daily life. As seen
in daily step counts, this varied widely among participants (Figure 5.2). Thus, we
should potentially view accommodation as a function of steps taken, rather than in
days of use.
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Table 5.3: User feedback and changes in capacity and performance
Given the varied metabolic responses to the powered prosthesis, we also explored if
users perceived walking to be easier with the powered prosthesis. Five participants felt
that walking with the powered prosthesis was easier while four participants responded
that walking with the powered prosthesis was harder. Of the five participants that
felt walking with the powered prosthesis was easier, only one had reduced metabolic
cost with the powered prosthesis, while another had greater metabolic cost (Table
5.3). Similarly, of the four participants that felt walking with the powered prosthesis
was harder, one had increased metabolic cost, while another had decreased metabolic
cost with the powered prosthesis. This agrees with prior work that found that the
perception of exertion contrasts to the physiological measure of metabolic cost [139].
Further, we explored how everyday physical activity levels might reflect changes
in metabolic costs or perceived ease of walking. Among the five participants that felt
walking with the powered prosthesis was easier, only one increased their daily step
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count (Table 5.3). Physical activity in daily life may be more dependent on factors
other than the prosthesis, such as the surrounding environment, weather, lifestyle,
personality, and occupation. In particular, walking with the powered prosthesis is
more destabilizing when walking on icy or otherwise slippery surfaces, which may
have influenced participants’ walking patterns and confounded our results. Though
we could not control the weather conditions, we did collect each participants’ activity
with both prostheses in a single season, when possible (Appendix B.1). Similar to
our findings, a previous study evaluating the effects of a microprocessor knee found
no differences in everyday activity [88].
Participants also had varied feelings about the powered prosthesis and how it im-
proved or did not improve their function. Four preferred their prescribed, unpowered
prosthesis while six preferred the powered prosthesis. Prosthetic preference was not
related to changes in metabolic cost or walking speed. While there was no relationship
between prosthetic preference and measures of functional capacity or performance,
participants who preferred the powered prosthesis tended to feel that the powered
device helped them walk for longer without rest, faster (Appendix B.3), and with
more ease (Table 5.3). This user feedback may provide information regarding the
factors that determine prosthetic preference and/or acceptance.
There were differences between participants’ perception of their function and their
performance in daily life. While six participants responded that they felt they could
walk faster with the powered prosthesis, only three walked faster in-lab by more than
0.108 m/s (MDC for older adults in 4-meter walk tests) [55], and only one walked
faster in daily life, by an amount far less than the in-lab MDC of walking speed (Table
5.3). Furthermore, while five participants responded that they felt they could walk for
longer with the powered prosthesis, only two participants increased their daily step
count. Comparing qualitative user feedback and measures of step count and walking
speed in daily life, there seemed to be a disconnect between what people perceived
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they were capable of doing and what they did in daily life. This dissonance is sup-
ported by the weak correlations between changes in step count and changes in the
PEQ ambulation sub-scale and changes in the SF-36 physical functioning sub-scale.
This suggests that future research and clinical approaches to prescription should con-
sider both perception and objective measures. This is important as daily prosthetic
use is largely dependent on an individual’s feelings about their function, while device
prescription is predominantly supported by more objective measurable outcomes.
Psycho-social responses to the powered prosthesis may affect physical activity,
especially in community settings. Participants perceiving less social burden with
the powered prosthesis contrasted with previous findings with a younger cohort [38],
which suggests that psycho-social responses may be age-dependent. This may be at-
tributed to the higher likelihood for older individuals to be in co-dependent domestic
relationships, as the social burden sub-scale describes one’s perception of how the
prosthesis affects the relationships with their partner or family members [91]. How-
ever, the weak correlations between changes in community engagement and changes
in psycho-social sub-scales of the PEQ and SF-36 suggest that other factors may in-
fluence community engagement more strongly. A more practical limiting factor for
community engagement may be the short battery life, as expressed in user feedback
by six participants. Because the heavy weight of the powered prosthesis is more no-
ticeable when the battery dies and makes walking harder, users may choose to engage
in the community only when they are equipped with several fully charged batteries.
The Ottobock Empower (current version of the BiOM) has a battery life of 8 hours,
which may alleviate these issues. However, battery life is dependent on intensity of
use and may still be a concern for very active individuals who would require a battery
change for all-day use.
This study had several limitations. Walking speed in daily life was calculated
from all straight-line over-ground walking strides, which had variable sample sizes as
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participants did not all log the same number of strides in daily life. We addressed this
issue by calculating the bootstrapped mean of walking speeds, thereby minimizing
bias caused by varied sample sizes. Further, consistent with previous studies done in
the lab [63, 130, 49], we focused only on straight-line strides and thus did not include
turning strides or stair-walking. While more work can be done toward specifically
identifying and examining non-straight-line walking, this may require additional sen-
sors on the hip or intact foot. We chose to only attach the sensors directly on the
prosthetic foot to minimize the day-to-day variability in sensor placement and maxi-
mize sensor wear time. Further, data for the powered prosthesis may include steps for
which the person did not receive power, either because the battery died or because the
participant turned it off (e.g., to traverse uneven terrain). We cannot identify these
steps based on the data from our sensors. Based on participant feedback, however,
we expect that theses instances represent a very small portion of measured steps. As
mentioned above, weather conditions may have also affected everyday performance.
While collections for different prostheses were done mostly in the same season, one
participant’s everyday activity was collected in different seasons due to scheduling
conflicts (Appendix B.1). Additionally, some variability in performance may be due
to lifestyle or life events (e.g., vacation, hospitalization), rather than the prosthesis.
No participants reported such events in their activity logs, though several participants
were retired and did not have a regular day-to-day schedule. Lastly, this study was
limited by a small sample size due to difficulties in recruitment. To mitigate these
difficulties, we amended the study to additionally recruit K4 participants, which fur-
ther diversified the already heterogeneous cohort of K3 participants. The low sample
size increases the likelihood of type II errors. To address this issue, we have provided




This study compared participants’ metabolic costs, walking speeds in-lab and in
daily life, step count, step count away from home, perceived mobility, and preference
between powered and unpowered prostheses. There was no statistically significant
preference for either prosthesis. Additionally, wearing the powered prosthesis did not
significantly decrease metabolic costs, increase physical activity or walking speed, or
increase perceived mobility. Though the powered prosthesis was not universally ben-
eficial to the participant cohort, the large variability in responses across participants
suggests that different people may benefit in different ways and to varying degrees.
Regarding the powered prosthesis, participants reported feeling they could walk faster
and with more ease, while battery life and weight were prevalent complaints. There
was disparity between participants’ perceptions of their mobility and what they per-
form during daily life when using the powered prosthesis. This suggests that future
research should continue to examine both perception and objective measures of mo-




Quantifying the Effect of Powered Prostheses on
Toe Clearance Using Inertial Measurements
6.1 Introduction
After a transtibial amputation (TTA), people are more prone to trips and falls
[90, 98]. This may be due to the inability of the prosthetic foot to actively dorsiflex
during swing, which contributes to a low minimum toe clearance (MTC) [31, 52].
MTC is defined as the vertical distance between the lowest point of the foot and the
ground at the minimum point of swing. The failure to achieve an adequate MTC
during swing leads to stumbles or trips, that may result in falls. To compensate,
individuals with TTA may increase their residual limb hip and knee flexion for the
foot to clear the ground [103, 52]. Due in part to these compensations, individuals
with TTA have greater MTC variability [78], which may contribute to increased risk
of falls [10].
Most commercially available prosthetic feet are passive and unpowered, classified
as solid ankle cushion heel (SACH) feet that provide stability to the user, or as
energy storage and return (ESAR) feet that store energy during loading response
and return energy during push-off. Commercially available powered prostheses have
been developed to better replicate the active function of the biological ankle. One
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such device is the Proprio Foot (Ossur, Reykjavik, Iceland), which provides active
dorsiflexion during swing and has been shown to increase MTC in individuals with
TTA [129]. However, the Proprio Foot does not replicate the active plantarflexion
function of the biological ankle. The BiOM T2 (now Ottobock Empower, Duderstadt,
Germany) is the only commercially available prosthesis that provides active push-off
torque at the prosthetic ankle. The BiOM powered prosthesis has been shown to
produce comparable step-to-step transition work at the trailing prosthetic limb to
that of the intact limb [130] and may help initiate swing by replicating the push-off
function of the biological plantarflexors [108]. However, qualitative user feedback has
shown a potential for the heavier BiOM prosthesis to affect stability and fall risk
[Chapter 5].
MTC has been primarily measured using motion capture systems. As such, the
effects of powered prostheses on MTC have been quantified in well-constrained labo-
ratory environments. The Proprio Foot active dorsiflexor prosthesis has been shown
to increase MTC in treadmill walks, though MTC variability was not affected [129].
In the same study, the authors introduced the “likelihood of tripping curve” that rep-
resents the likelihood of contacting a hypothetical, unseen obstacle of a specific height
at the point of MTC by calculating the cumulative probability distribution from all
MTC values measured during the treadmill walk. The active dorsiflexor foot was
shown to decrease the likelihood of contacting a hypothetical obstacle with a 5mm
height. On a loose rock surface, the BiOM powered prosthesis has also been shown
to increase MTC relative to that of unpowered prostheses but not to the level of the
intact limb [50]. While participants increased their MTC with the powered prosthe-
sis, mean differences were small, the powered prosthesis was in a more plantarflexed
position, and there were no kinematic differences at the hip or knee joints between
prostheses. Thus, authors attributed the increase in MTC to the small changes in
intact limb knee flexion during stance.
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To date, the effects of a powered prosthesis on MTC in daily life have not been
quantified. While motion capture systems are capable of measuring MTC and joint
kinematics concurrently, findings may be limited by the size of the motion capture area
and the number of walking surfaces that can be simulated in the laboratory. MTC has
been found to be sensitive to the walking surface in individuals with [52] and without
TTA [135]. Thus, it is important to examine the effects of prosthetic interventions on
a variety of real-world environments. Further, measuring MTC variability in walks
over straight, level-ground walkways or treadmills may provide useful information on
internal sources of movement variability, but limited information on external sources
for variability. In contrast individuals experience many external sources for MTC
variability in daily life (e.g., turning, changing speed, obstacle navigation, traversing
slopes). Measuring MTC variability from a distribution of MTC values derived from
everyday walking may provide additional information on the real-world effects of the
powered prosthesis on fall risk.
The use of foot mounted inertial measurement units (IMU) and inertial navigation
algorithms have enabled researchers to estimate the position trajectory of the IMU
and calculate stride-by-stride spatiotemporal parameters in a variety of unconstrained
environments [110, 122, 85]. Various works have demonstrated the ability to use the
position estimates of the IMU to calculate MTC in a research setting [95, 28, 82, 87,
12]. Only one of these works have measured MTC with a clinical purpose, though
gait analysis was done along an indoor 20 m walkway [28].
Previous approaches of estimating MTC have shown mean absolute error rates
of 10 to 30% when compared to motion capture estimates [12, 87, 95, 82]. However,
these approaches require prior knowledge of shoe size [95] or the assumption of a level-
ground during foot-flat [95, 12, 87]. These assumptions may present difficulties in
analyzing walking data from the free-living environment. Additionally, some studies
calculated the vertical position displacement of the IMU between foot-flat and at the
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low-point of swing [12, 87], which measures the relative clearance of the foot. This
approach assumes that the foot’s orientation during its lowest point of swing is the
same as its orientation at foot-flat and is not sensitive to variations of the foot’s pitch
angle during swing. Because most prosthetic feet cannot dorsiflex and remain at their
neutral angle during swing, users compensate with increased hip and knee flexion,
the foot’s sagittal angle may vary during swing, suggesting an increased likelihood
for error in estimating MTC in individuals with TTA. One previous study presented
a method of estimating the location of the IMU relative to the toe and heel points
without prior knowledge of shoe size [82]. However, this approach may be difficult to
implement to everyday walking data, as it used inertial estimates of position at single
time points of estimated toe-off and heel-strike and may be over-reliant on robust
detection of these gait events and accurate position estimates.
The purpose of this study was to quantify the effects of the BiOM powered pros-
thesis on MTC and MTC variability in daily life. We first compared the relative
feasibility of a novel method for calculating MTC using inertial signals and a pub-
lished method for MTC calculation in the lab, tested against motion capture-based
estimates (Feasibility study). We then conducted a randomized clinical trial of a
powered prosthesis in ten individuals with TTA (Prosthetic comparison study). Our
central hypothesis was that MTC would not be lower and MTC variability would not
be higher with the powered prosthesis compared to the unpowered prosthesis.
6.2 Methods
6.2.1 Participants
We recruited individuals with transtibial amputation (TTA) through clinical re-
ferral from the University of Michigan Orthotics and Prosthetics Center and through
postings on https://umhealthresearch.org and https://clinicaltrials.gov. We included
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participants with unilateral TTA, aged 21 years or older, and having used a prosthesis
for at least six months. We excluded potential participants if they had a history of
cardiovascular disease, orthopedic or neurological disorders to their intact limb, or
were unable to walk independently for 10 minutes at a time. One male with TTA
(age: 39 years, height: 1.76 m, weight: 79 kg) participated in the feasibility study.
Ten other males with TTA (age: 46.5 ± 14.9 years, height: 1.79 ± 0.07 m, weight: 97
± 20 kg) participated in the prosthetic comparison study. All participants provided
their written informed consent prior to participating in these studies, which were
approved by the University of Michigan Institutional Review Board (HUM00080734).
6.2.2 Experimental Protocol
In the feasibility study, the participant came to the laboratory for a single session
of testing. The participant walked on a level-ground 7-meter walkway at self-selected
preferred speed for 10 trials, after which the mean walking speed was determined.
This process was repeated for self-selected slow and fast speeds. The participant then
walked on the treadmill at the predetermined slow (0.70 m/s), preferred (1.23 m/s),
and fast (1.88 m/s) speeds for at least 2 minutes each, coming to a full stop after each
speed. We placed an IMU (Actigraph GT9X Link, Actigraph, Pensacola, FL, USA)
on the shoe of the prosthetic limb (Figure 6.1). The IMU collected accelerometer
and gyroscope data at 100 Hz. We recorded kinematic data of the treadmill walking
protocol at 120 Hz, using a motion capture system (Motion Analysis, Rohnert Park,
CA). Reflective markers were placed on the IMU, the medial and lateral malleoli,
heel, lateral heel, and 5th and 2nd metatarsals. Reflective tape was placed on the
anterior tip of the shoe (TOE; Figure 6.1). Reflective markers were also placed on
the treadmill to locate the ground surface.
The prosthetic comparison study used a cross-over design where participants were
tested with their prescribed, unpowered prosthesis and the BiOM T2 powered pros-
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Figure 6.1: Placement of inertial measurement unit (IMU) and reflective markers.
thesis (BionX Medical Technologies Inc., Bedford, MA, USA) in random order. A
certified prosthesis fit the participants with the powered and unpowered prostheses.
After a change in prostheses, participants were given one week to acclimate to the
device. If needed, participants returned to the clinic for adjustments or changes to
alignment, after which they were given another week to acclimate. Participants were
then given an IMU to wear on top of their prosthetic shoe for two weeks.
6.2.3 Data Processing and Analysis
We compared motion capture-based estimates of MTC and two methods of calcu-
lating MTC using IMU-derived position estimates. First, marker position data from
motion capture were low pass filtered using a 4th order Butterworth filter with a 6
Hz cut-off frequency. MTC were calculated from motion capture data by subtracting
the vertical position of the ground marker from that of the TOE marker during the
TOE marker’s local minimum position during swing (MTCMocap).
The position of the IMU was calculated using pedestrian dead reckoning algo-
106
rithms described in [110, 122]. These algorithms rely on an assumption that the foot
does not slip on the ground during foot-flat. First, during a period of low movement
detected using the gyroscope signal, we oriented the IMU to the lab reference frame
(Figure 6.2A). We then applied zero velocity updates (ZUPT) to the acceleration sig-
nal at every foot-flat, so that the velocity of the IMU (integrated from acceleration)
during foot-flat was corrected to be zero, which simultaneously removed the accel-
eration signal due to gravity. We then integrated the resulting acceleration signal
twice to calculate the position trajectory of the IMU. As done with previous studies
to estimate MTC, we used the position trajectory of the IMU to calculate relative
foot clearance (RFC) as the relative vertical displacement of the IMU between its po-
sition during foot-flat and its position during the lowest point of swing [12, 87]. This
method of estimating MTC by way of a proxy measure of foot clearance assumes the
orientation of the foot during the lowest point of swing is the same as its orientation
at foot-flat. Therefore, this estimate would not be sensitive to changes in the foot’s
sagittal angle, which would in fact alter the actual MTC.
We attempted to address this shortcoming with a novel method that approximated
the location of the toe during swing. In addition to the no-slip assumption, this
approach relies on a further assumption that between foot-flat and toe-off, the foot
rotates about a stationary center of rotation (CoR), which is approximately the toe
point, at an equidistant moment arm (Figure 6.3). We detected toe-off as the local
maximum of the sensor’s pitch angle. The location of the CoR was calculated using








×−→src +−→sωs × (−→sωs ×−→src)
where −→sas is the acceleration of the IMU sensor in the sensor frame, −→sac is the
acceleration of the CoR in the sensor frame, −→sωs is the angular velocity of the sensor,
and −→src is the moment arm that describes the location of the CoR in the sensor frame.
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Figure 6.2: Flowchart: algorithm schematics
Algorithm schematics for the IMU-based measures of A. relative foot clearance
(RFC) and B. minimum toe clearance using the center of rotation assumption
(MTCCoR).
Figure 6.3: Sensor’s rotation about the stationary center of rotation (CoR)
The constant moment arm vector (−→src) between foot-flat and toe-off describes the
displacement of the CoR point from the IMU in the IMU reference frame. The
moment arm vector can be solved using acceleration (−→sas) and gyroscope (−→sωs)
signals from the IMU.
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With the stationary CoR assumption, the equation was simplified as follows.
−→




×−→src +−→sωs × (−→sωs ×−→src)
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where −→sas and −→sωs are extracted from the sensor signals. −→src was calculated at
every time point in each stride between foot-flat and toe-off where the sensor’s pitch
angular velocity was greater than 50% of the local maximum. Signals with low angular
velocity were excluded as they were likely to have a low signal to noise ratio. We then
calculated a single moment arm estimate as the mean of all calculated moment arm
values. The calculated mean moment arm was then rotated to the lab reference
frame and subtracted from the IMU position trajectory (Figure 6.2B) to calculate
the position trajectory of the approximated toe during swing. MTC was estimated
as the vertical displacement of the approximated toe during the lowest point of swing
(MTCCoR). We excluded strides if foot-flat could not be detected within the stride.
In daily life, non-sedentary bouts of activity were detected using the IMU signal
and ActiLife software (ActiGraph, Pensacola, FL, USA) as any period in which the
acceleration vector magnitude exceeded 30 counts per minute and lasted at least 1
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minute [143]. Within these bouts, we identified valid straight-line walking strides
using a rule-based algorithm as described in [85]. We excluded strides taken on
stairs by eliminating strides with a vertical displacement between consecutive foot-
flats that exceeded the standard star height of 17.8 cm [53]. Using the above system
of equations, we calculated moment arms at every valid stride and took the mean
for every bout, as the placement of the IMU is not likely to change during a bout
of walking but may change between periods of rest. MTC were calculated on these
valid strides using the bout-wide mean moment arm calculations. Within-bout MTC
variability was calculated as the standard deviation of MTC values within every bout
of walking with 8 or more strides.
6.2.4 Statistical Analysis
In the feasibility study, we tested for fixed effects in the measurement method
(MTCMocap, RFC, MTCCoR) and speed (slow, preferred, fast) factors and an inter-
action effect (method × speed) using a linear mixed model. To examine the relative
accuracy of MTC estimates, we also reported the mean absolute difference between
IMU-based measures (RFC, MTCCoR) and MTCMocap. In the prosthetic comparison
study, participants had varying sample sizes for MTC (N = number of strides) and
MTC variability (N = number of bouts) estimates over two weeks. To adjust for the
different sample sizes between participants and prostheses, we bootstrapped each set
of MTC before calculating the mean. For a set of n values, we sampled n elements
with replacement then calculated the mean of the resampled set. This process was
repeated 1000 times, and the bootstrapped mean was the mean of all 1000 resampled
means [123]. We tested for differences in the bootstrapped means of MTC and MTC
variability between prostheses in daily life using paired t-tests. Significance was set
to p < 0.05 for all comparisons. To address the low number of participants, we also
calculated the effect sizes for MTC and MTC variability using Hedge’s g :
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(SD2Powered(nPowered − 1)) + (SD2Unpowered(nUnpowered − 1))
nPowered + nUnpowered − 2
where Mx is the mean of group x, SDpooled is the pooled standard deviation, N is
the sample size, SDx is the standard deviation within group x, and nx is the sample
size of group x [36]. An effect size is small if 0.2 ≤ g ≤ 0.5, medium if 0.5 ≤ g ≤ 0.8,
and large if g ≥ 0.8 [23].
6.3 Results
6.3.1 Feasibility Study
There were significant method (p < 0.001), speed (p < 0.001), and method ×
speed (p < 0.001) interaction effects in MTC. Post-hoc pairwise comparisons revealed
no differences between MTCMocap and RFC (p = 0.535) or between MTCMocap and
MTCCoR (p = 1.000) at the slow walking speed (Figure 6.4). At the preferred walking
speed, RFC was greater than MTCMocap (p < 0.001) while MTCCoR was not different
to MTCMocap (p = 1.000). At the fast speed, both RFC (p < 0.001) and MTCCoR
(p < 0.001) were different to MTCMocap. The mean absolute differences between
MTCMocap and RFC and MTCCoR are reported in Table 6.1.
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Figure 6.4: Toe clearance estimates from the feasibility study
Toe clearance results plotted for motion capture estimates (MTCMocap), IMU-based
estimates of relative foot clearance (RFC), and IMU-based estimates of toe
clearance using approximated location of toe (MTCCoR). Significant pairwise
differences between MTCMocap and RFC or MTCCoR were denoted (*).
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Figure 6.5: Toe clearance and its variability in daily life
Results from the prosthetic comparison study: A. toe clearance estimates and B.
within-bout toe clearance variability. Individual trends were plotted as gray lines.
6.3.2 Prosthetic Comparison Study
Two participants’ IMU data from daily life did not collect sufficient data due
to potential battery malfunctions and were excluded from analysis. From the two-
week collection, we estimated MTC values of 7600 ± 4950 strides from participants
wearing the unpowered prosthesis and 9470 ± 8710 strides from participants wearing
the powered prosthesis. We calculated within-bout MTC variability from 181 ±
135 bouts with the unpowered prosthesis and 214 ± 211 bouts with the powered
prosthesis. There were no differences between prostheses in MTCCoR (p = 0.792) or
MTCCoR variability (p = 0.329) in daily life. There were also no differences between
prostheses in RFC (p = 0.588) or RFC variability (p = 0.335) in daily life (Figure
6.5). The effect sizes for these comparisons were small (|g| ≤ 0.228; Table 6.2).
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Table 6.2: Comparisons of toe clearance and its variability between prostheses
6.4 Discussion
6.4.1 Evaluating Fall Risk in Daily Life
Our central hypotheses that the powered prosthesis would not decrease partic-
ipants’ minimum toe clearance (MTC) and increase MTC variability in daily life
were supported. When estimated using the center of rotation (CoR) assumption
(MTCCoR), there were no differences between prostheses in MTC or MTC variabil-
ity in daily life. This finding was consistent when evaluating relative foot clearance
(RFC) and its variability. Therefore, we did not detect an increase in fall risk with
the powered prosthesis in daily life.
6.4.2 Feasibility of the Center of Rotation Assumption
Using the motion capture-based estimate of MTC as reference, MTC using the
CoR assumption had smaller mean absolute differences compared to that of RFC
over the three tested walking speeds (Table 6.1). Assuming the MTCMocap measure
is the most accurate estimate of MTC, MTCCoR and RFC measures did not perform
differently at slow and fast speeds. At the preferred speed, however, MTCCor was a
more accurate estimate than RFC. The relative advantage of MTCCoR over RFC can
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also be realized by examining the effects of speed on MTC. There were no differences
between speeds in MTCMocap, which suggests that walking speed did not affect MTC
for this participant. This finding agrees with a previous study in which individuals
with TTA did not alter their prosthetic side MTC when walking at different speeds
[31]. However, while MTCMocap and MTCCoR were not different in the slow and
preferred speeds, RFC was different to MTCMocap at the preferred speed but not at
the slow speed. An increase in walking speed is associated with increased stride length
[86] and thus a decrease in the vertical distance between the hip joint and ground.
With the prosthetic ankle fixed at its neutral angle, increased hip and knee flexions
may be required to ensure ground clearance [103, 135] and the prosthetic foot’s toe
may be closer to the ground during swing. This may explain the different trends in
how RFC and MTCCoR change between slow and preferred speeds and lend credence
to the relative advantage of the MTCCoR estimate in being able to detect variation
in toe clearance that may not be detectable by RFC.
At the fast speed, both RFC and MTCMocap were significantly different to MTCMocap,
with high variability. This could be attributed to the IMU shifting around during
stance, as it was loosely mounted using a cloth pouch. The IMU not being prop-
erly secured to the shoe would detract from the algorithm’s ability to properly apply
the zero velocity update during foot-flat and increase noise in the position estimates.
However, the fast speed (1.88 m/s) is much faster than the range of speeds that indi-
viduals with TTA usually walk at in daily life (∼ 0.6 – 1.3 m/s) [85], thus calculation
problems at this speed may not be prevalent in everyday walking data. Future work
that aim to test faster walking speeds may benefit from applying a tight wrap around
the foot-mounted IMU as done in previous studies on running biomechanics [111].
The motion capture-based MTC estimates and its variability (standard deviation)
from in-lab treadmill walking were comparable to published values for MTC and
within-subject MTC variability as measured in previous in-lab studies on individuals
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with TTA [31, 78, 129]. At the slow and preferred speeds, IMU-based toe clearance
estimates were also similar to published values, though with higher variability.
6.4.3 Prosthetic Comparison in Daily Life
RFC and MTCCoR estimates and their variability in daily life were not different to
each other. Both MTC and within-bout MTC variability were higher than published
values from in-lab studies [31, 78, 129]. Higher MTC and MTC variability in daily
life may be attributed to participants navigating obstacles, stepping onto curbs that
are lower than standard stair heights, walking on various terrains, and transitioning
between different terrains. The MTC variability measure in daily life may not be
able to detect changes in gait due to a prosthetic intervention, as the results from the
in-lab feasibility study showed that IMU-based MTC variability may be dominated
by variability in the calculation algorithm rather than kinematic variability, which
contains more meaningful information regarding fall risk.
While the variability of MTC in daily life may not contain salient information, the
distribution of MTCCoR values in daily life provides more information about the effects
of the powered prosthesis. With the unpowered prosthesis, the group wide mean
MTCCoR distribution has a positive skew, indicating a greater concentration of MTC
values below the mean (Figure 6.6). While the MTCCoR distribution with the powered
prosthesis also has a positive skew, relative to that of the unpowered prosthesis,
MTC values with greater probability density were shifted toward higher toe clearance
values. That is, MTC was likely to be higher with the powered prosthesis than with
the unpowered prosthesis. Using the RFC estimate for toe clearance, there was no
noticeable difference between prostheses in the distribution skew of toe clearance
values. This may suggest that in everyday walking strides, the foot’s orientation
during the low point of swing is such that the toe is pointing more downward with
the unpowered prosthesis, compared to the powered prosthesis.
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Figure 6.6: Distribution of toe clearance values in daily life
Split violin plot of the probability density functions of distributions of relative foot
clearance (RFC) and minimum toe clearance using the center of rotation
assumption (MTCCoR) in daily life. Raw distributions were smoothed using the




In exploring the feasibility of our approach to estimating MTC, we were only able
to collect data from one participant with TTA, due to COVID-19 restrictions. Fur-
ther validation with greater statistical power is required to support the claims made
in the feasibility study. Additionally, our in-lab protocol utilized a treadmill walking
activity. While there may not be significant kinematic differences between treadmill
and overground walking [125], treadmill walking may constrain kinematic variabil-
ity [67] and inherently limit some of the variability in MTC. Thus, future studies
should validate these results in overground walking. Finally, the theoretical validity
of the stationary CoR assumption also relies on the foot being a rigid component.
While this assumption may be easily broken in the biological foot and articulating
metatarsal joint, the carbon fiber prosthetic keel component is stiff. Thus, we made
the assumption that the resulting deflection between the toe point and the IMU would
be negligible.
6.5 Conclusion
This study explored a novel method of assessing fall risk in daily life by estimating
minimum toe clearance (MTC) using IMU signals. This approach aimed to improve
on existing methods by approximating the location of the toe in relation to the foot
mounted IMU during swing. We applied this approach to quantify the effects of
the powered prosthesis on MTC in all straight-line level steps taken in a two-week
period. There were no differences in MTC or MTC variability between powered and
unpowered prostheses in daily life. Thus, the powered prosthesis may not affect users’




7.1 Summary and Recommendations for Future Work
There are several gaps in existing literature regarding the effectiveness of powered
prosthetic feet. This dissertation addresses these gaps by quantifying how the powered
prosthesis impacts the user’s neuromuscular strategy and fatigue-related compensa-
tions using experimental approaches in the lab. This work further expands the scope
of prosthetic evaluation by quantifying gait characteristics in everyday life. To do
this, I examined the clinical viability of several novel approaches for characterizing
mobility using wearable sensors. My work can therefore be categorized into two areas:
the analysis of functional capacity demonstrated by users in laboratory experiments
(Chapters 2 and 3) and the examination of walking performance demonstrated by
users in their daily lives (Chapters 4, 5, and 6). Findings from this work can provide
important information regarding the implications for prosthetic prescription, design,
and evaluation paradigms.
The primary purpose of the prosthesis is to replicate the biological limb to re-
store pre-amputation levels of mobility. The effects of the powered prosthesis on
metabolic cost, endurance, walking speed, and step count are subject-specific and
not universal. No single participant improved in all metrics of mobility, and improve-
ments may be accompanied by trade-offs in other metrics. Therefore, in prescribing
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the powered prosthesis, clinicians may benefit from understanding the patient’s spe-
cific desired outcomes and adopting realistic expectations for potential shortfalls.
Metabolic reductions in powered prosthesis users were shown in earlier studies [7, 63]
and used as a common evaluation metric for the device’s effectiveness. However,
not all users experience metabolic reductions. I revealed a moderate relationship be-
tween co-contractions at the residual limb thigh and metabolic cost, which suggests
that individuals who are able to effectively stabilize their residual limb during stance
may experience metabolic benefits (Chapter 2). Thus, if the clinician’s primary goal
of prescribing the powered prosthesis is to reduce the patient’s metabolic cost, the
prescription may be more effective for a select group of individuals that are already
able ambulators. However, the ability to effectively stabilize the residual limb may
be a subjective and under-defined criterion. Thus, future work should examine the
effects of directed training schemes involving strengthening the residual limb stabilizer
muscles.
Before we invest solely in metabolic reductions as the determining criterion for
prosthetic evaluation, we must also consider if metabolic benefits affect the user’s
mobility. Interestingly, metabolic reductions associated with the powered prosthesis
likely do not manifest into improved walking endurance or increased physical activity
in daily life (Chapters 3 and 5). The powered prosthesis may, however, cause less
pain or discomfort at the socket-limb interface in long-duration walks, compared to
unpowered devices. If patients report socket pain or discomfort as a limiting factor
for healthy amounts of physical activity, these issues may be alleviated with the
powered prosthesis. However, this recommendation requires further work, as the
specific factors associated to the powered prosthesis that mitigate socket pain is not
yet clear. Therefore, further work is needed to understand the relationship between
the powered push-off and socket pain.
In addition to the powered prosthesis’ potential benefits to mobility, we must also
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be cognizant of its potential adverse effects on safety and fall risk. After a two-week
period of walking with the powered prosthesis in their daily lives, some participants
reported feeling unstable particularly when traversing outdoor terrains such as grass
or gravel (Chapter 5). In examining the potential for tripping-related falls in daily
life, I found that the powered prosthesis did not affect minimum toe clearance (Chap-
ter 6). As such, while the powered prosthesis did not increase the likelihood for
tripping due to a low toe clearance, it is unlikely to increase toe clearance. This may
serve as an important distinction between the powered prosthesis and active dorsi-
flexor prostheses (such as the Ossur Proprio Foot), which are more specialized for
actively increasing toe clearance. An important consideration here is my approach in
examining straight-line walking strides. Walking with the relatively heavier powered
prosthesis incurred greater activation at the intact limb gluteus medius, which may
be associated with greater frontal plane moments at the hip (Chapter 2). This finding
may have implications for compensatory strategies when making turns. Thus, it is
unclear if users are more or less susceptible to falls during turning steps with the
powered prosthesis, and future work should characterize balance and fall risk with the
powered prosthesis for turning steps.
The benefits of the powered prosthesis are non-universal and inconclusive, which
suggests there may be design considerations that require further attention. Of partic-
ular interest is the relatively stiff keel of the powered prosthesis, which may limit its
ability to provide a stable loading response and weight acceptance during the residual
limb’s stance phase. Increased activations at muscles responsible for stabilizing the
limb during stance suggest that the powered prosthesis incurs a greater need to stabi-
lize the residual limb (Chapter 2). These increases were large enough to be perceived
by several participants who reported stability issues (Chapter 5). This issue may
also impact walking endurance. The fatigue- and device-related increases in power
absorption at the intact limb ankle during loading response could be attributed to
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the lack of power absorption at the powered ankle or a misalignment in the timing
or magnitude of the powered push-off that becomes apparent after fatigue (Chapter
3). These effects are yet to be fully quantified and future work should examine ways
to alleviate stability issues at the residual limb during stance.
7.2 Long-term Vision
My unique contribution to the body of work evaluating the powered prosthesis is
the use of wearable sensors to characterize gait in daily life. In addition to measur-
ing functional capacity in the lab, measuring the performance of mobility in daily life
takes an important step toward evaluating the real-world impact of prosthetic devices.
I anticipate that as the mobility measures examined in Chapters 4 to 6 are refined,
standardized, and validated, prosthetic evaluation studies will trend toward taking
place in patients’ everyday lives. To successfully characterize or evaluate gait in daily
life, it is imperative that clinicians and engineers collectively work toward establish-
ing and refining outcomes that can be quantified in daily life. One example is the
concept of variable cadence, which has long been a part of the Medicare Functional
Classification Level guidelines. There is a large variability in how clinicians assess this
trait in the clinic, which contributes to a large variability in functional classification.
This can lead to uncertainty in how cadence variability should be quantified in daily
life. Thus, the process of implementing clinical outcomes to be measured in daily life
may not always be straightforward and may require careful interpretation.
Given the widespread use of wearable sensors, such as the Fitbit (Fitbit, CA,
USA) and Apple Watch (Apple, CA, USA), to track our daily activity today, I be-
lieve there is an avenue for integrating sensors to microprocessor prosthetic devices.
Embedding an IMU sensor within the prosthetic component would not only mitigate
sensor noise, but also provide pathways to various clinical and technological applica-
tions. Currently, when a patient is first prescribed the powered prosthesis, a certified
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prosthetist will observe the patient walking in the clinic with the prosthesis, while
iteratively tuning the device’s stiffness, push-off and timing parameters. Once both
the patient and clinician are satisfied, the parameters are set and only changed if
patients return for additional tuning. While the manufacturer suggests that users
can quickly learn to walk with the device, user feedback from Chapter 5 suggests that
this learning process was not always immediate. Given the foundation laid in this
work, the data collected during everyday walking could provide useful information
to clinicians about the user’s learning and acclimation process. Further, data from
the embedded sensors could also provide users with feedback on their walking perfor-
mance. An effective prosthetic intervention does not necessarily occur during a single
clinic visit. As such, facilitating a successful adaptation to the device and promoting






Appendix for Chapter 3
125
Table A.1: Spatiotemporal parameters (pairwise p value and Hedge’s g)
Table A.2: Ground reaction force peaks (pairwise p value and Hedge’s g)
126
Table A.3: Joint power peaks (pairwise p value and Hedge’s g)
127
Table A.4: Joint ranges of motion (pairwise p value and Hedge’s g)
128
Table A.5: Peak joint angle, moment, and power at the hip, knee, and ankle
129
Table A.6: Symmetry indices for joint angle, moment, and power
130
APPENDIX B
Appendix for Chapter 5
131
Table B.1: Accelerometer (ACC) sensor data collection month and quantity
Table B.2: IMU sensor data collection month and quantity
132





[1] Mark V Albert, Cliodhna McCarthy, Juliana Valentin, Megan Herrmann, Kon-
rad Kording, and Arun Jayaraman. Monitoring functional capability of individ-
uals with lower limb amputations using mobile phones. PloS one, 8(6):e65340,
2013.
[2] Frank C Anderson and Marcus G Pandy. Individual muscle contributions to
support in normal walking. Gait & posture, 17(2):159–169, 2003.
[3] Elisa S Arch, Ozan Erol, Connor Bortz, Chelsea Madden, Matthew Galbraith,
Anthony Rossi, Jessica Lewis, Jill S Higginson, Jenni M Buckley, and John
Horne. Real-world walking performance of individuals with lower-limb amputa-
tion classified as medicare functional classification level 2 and 3. JPO: Journal
of Prosthetics and Orthotics, 28(2):51–57, 2016.
[4] Elisa S Arch, Ozan Erol, Connor Bortz, Chelsea Madden, Matthew Galbraith,
Anthony Rossi, Jessica Lewis, Jill S Higginson, Jenni M Buckley, and John
Horne. Method to quantify cadence variability of individuals with lower-limb
amputation. JPO: Journal of Prosthetics and Orthotics, 29(2):73–79, 2017.
[5] Kristin R Archer, Renan C Castillo, Ellen J MacKenzie, and Michael J Bosse.
Gait symmetry and walking speed analysis following lower-extremity trauma.
Physical therapy, 86(12):1630–1640, 2006.
[6] Samuel K Au, Jeff Weber, and Hugh Herr. Biomechanical design of a powered
ankle-foot prosthesis. In Rehabilitation Robotics, 2007. ICORR 2007. IEEE
10th International Conference on, pages 298–303. IEEE, 2007.
[7] Samuel K Au, Jeff Weber, and Hugh Herr. Powered ankle–foot prosthesis im-
proves walking metabolic economy. Robotics, IEEE Transactions on, 25(1):51–
66, 2009.
[8] PA Baker and SR Hewison. Gait recovery pattern of unilateral lower limb am-
putees during rehabilitation. Prosthetics and orthotics international, 14(2):80–
84, 1990.
[9] AJ Baliunas, DE Hurwitz, AB Ryals, A Karrar, JP Case, JA Block, and TP An-
driacchi. Increased knee joint loads during walking are present in subjects with
knee osteoarthritis. Osteoarthritis and cartilage, 10(7):573–579, 2002.
135
[10] RS Barrett, PM Mills, and RK Begg. A systematic review of the effect of
ageing and falls history on minimum foot clearance characteristics during level
walking. Gait & posture, 32(4):429–435, 2010.
[11] Hamid Bateni and Sandra J Olney. Kinematic and kinetic variations of below-
knee amputee gait. JPO: Journal of Prosthetics and Orthotics, 14(1):2–10,
2002.
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Alex Dickinson, Malcolm Granat, Laurence Kenney, Sisary Kheng, Mohammad
Sobuh, Robert Ssekitoleko, et al. Technology for monitoring everyday prosthe-
sis use: a systematic review. Journal of NeuroEngineering and Rehabilitation,
17(1):1–26, 2020.
136
[21] Pierre Cherelle, Arnout Matthys, Victor Grosu, Bram Vanderborght, and Dirk
Lefeber. The amp-foot 2.0: Mimicking intact ankle behavior with a powered
transtibial prosthesis. In 2012 4th IEEE RAS & EMBS international conference
on biomedical robotics and biomechatronics (BioRob), pages 544–549. IEEE,
2012.
[22] Rubana H Chowdhury, Mamun BI Reaz, Mohd Alauddin Bin Mohd Ali,
Ashrif AA Bakar, Kalaivani Chellappan, and Tae G Chang. Surface electromyo-
graphy signal processing and classification techniques. Sensors, 13(9):12431–
12466, 2013.
[23] Jacob Cohen. Statistical power analysis for the behavioral sciences. Academic
press, 2013.
[24] Steven H Collins and Arthur D Kuo. Recycling energy to restore impaired ankle
function during human walking. PLoS one, 5(2):e9307, 2010.
[25] Rosemary Corrigan and Helen McBurney. Community ambulation: Environ-
mental impacts and assessment inadequacies. Disability and rehabilitation,
30(19):1411–1419, 2008.
[26] Joseph M Czerniecki. Rehabilitation in limb deficiency. 1. gait and motion
analysis. Archives of physical medicine and rehabilitation, 77(3):S3–S8, 1996.
[27] Joseph M Czerniecki and David C Morgenroth. Metabolic energy expenditure
of ambulation in lower extremity amputees: what have we learned and what
are the next steps? Disability and rehabilitation, 39(2):143–151, 2017.
[28] Farzin Dadashi, Benoit Mariani, Stephane Rochat, Christophe J Büla, Brigitte
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Heel and toe clearance estimation for gait analysis using wireless inertial sensors.
IEEE Transactions on Biomedical Engineering, 59(11):3162–3168, 2012.
[96] Ryan S McGinnis and Noel C Perkins. Inertial sensor based method for identi-
fying spherical joint center of rotation. Journal of Biomechanics, 46(14):2546–
2549, 2013.
[97] Addie Middleton, Stacy L Fritz, and Michelle Lusardi. Walking speed: the
functional vital sign. Journal of aging and physical activity, 23(2):314–322,
2015.
143
[98] William C Miller, Mark Speechley, and Barry Deathe. The prevalence and risk
factors of falling and fear of falling among lower extremity amputees. Archives
of physical medicine and rehabilitation, 82(8):1031–1037, 2001.
[99] Peter M Mills, Rod S Barrett, and Steven Morrison. Toe clearance variability
during walking in young and elderly men. Gait & posture, 28(1):101–107, 2008.
[100] Olivier Missenard, Denis Mottet, and Stephane Perrey. The role of cocontrac-
tion in the impairment of movement accuracy with fatigue. Experimental brain
research, 185(1):151–156, 2008.
[101] Michaela Modan, Einat Peles, Hillel Halkin, Hedva Nitzan, Morris Azaria, San-
ford Gitel, Dan Dolfin, and Baruch Modan. Increased cardiovascular disease
mortality rates in traumatic lower limb amputees. The American journal of
cardiology, 82(10):1242–1247, 1998.
[102] Jana R Montgomery and Alena M Grabowski. Use of a powered ankle–foot
prosthesis reduces the metabolic cost of uphill walking and improves leg work
symmetry in people with transtibial amputations. Journal of The Royal Society
Interface, 15(145):20180442, 2018.
[103] Mufadal A Moosabhoy and Steven A Gard. Methodology for determining the
sensitivity of swing leg toe clearance and leg length to swing leg joint angles
during gait. Gait & posture, 24(4):493–501, 2006.
[104] David C Morgenroth, Alfred C Gellhorn, and Pradeep Suri. Osteoarthritis in
the disabled population: a mechanical perspective. PM&R, 4(5):S20–S27, 2012.
[105] David C Morgenroth, Ava D Segal, Karl E Zelik, Joseph M Czerniecki, Glenn K
Klute, Peter G Adamczyk, Michael S Orendurff, Michael E Hahn, Steven H
Collins, and Art D Kuo. The effect of prosthetic foot push-off on mechanical
loading associated with knee osteoarthritis in lower extremity amputees. Gait
& posture, 34(4):502–507, 2011.
[106] M Mussman, W Altwerger, J Eisenstein, A Turturro, A Glockenberg, and
L Bubbers. Contralateral lower extremity evaluation with a lower limb pros-
thesis. Journal of the American Podiatric Medical Association, 73(7):344–346,
1983.
[107] Virginia S Nelson, Katherine M Flood, Phillip R Bryant, Mark E Huang, Paul F
Pasquina, and Toni L Roberts. Limb deficiency and prosthetic management.
1. decision making in prosthetic prescription and management. Archives of
physical medicine and rehabilitation, 87(3):3–9, 2006.
[108] Richard R Neptune, SA Kautz, and FE Zajac. Contributions of the individual
ankle plantar flexors to support, forward progression and swing initiation during
walking. Journal of biomechanics, 34(11):1387–1398, 2001.
144
[109] Lauro Ojeda and Johann Borenstein. Non-gps navigation for security personnel
and first responders. The Journal of Navigation, 60(3):391–407, 2007.
[110] Lauro Ojeda and Johann Borenstein. Personal dead-reckoning system for gps-
denied environments. In 2007 IEEE International Workshop on Safety, Security
and Rescue Robotics, pages 1–6. IEEE, 2007.
[111] Lauro V Ojeda, Antonia M Zaferiou, Stephen M Cain, Rachel V Vitali, Steven P
Davidson, Leia A Stirling, and Noel C Perkins. Estimating stair running per-
formance using inertial sensors. Sensors, 17(11):2647, 2017.
[112] Michael S Orendurff, Silvia U Raschke, Lorne Winder, David Moe, David A
Boone, and Toshiki Kobayashi. Functional level assessment of individuals with
transtibial limb loss: evaluation in the clinical setting versus objective commu-
nity ambulatory activity. Journal of Rehabilitation and Assistive Technologies
Engineering, 3:2055668316636316, 2016.
[113] Michael S Orendurff, Jason A Schoen, Greta C Bernatz, Ava D Segal, and
Glenn K Klute. How humans walk: bout duration, steps per bout, and rest
duration. Journal of Rehabilitation Research & Development, 45(7), 2008.
[114] World Health Organization. International classification of functioning, disability
and health: Icf. 2001.
[115] Kim Parker, R Lee Kirby, James Adderson, and Kara Thompson. Ambulation
of people with lower-limb amputations: relationship between capacity and per-
formance measures. Archives of physical medicine and rehabilitation, 91(4):543–
549, 2010.
[116] JP Pell, PT Donnan, FGR Fowkes, and CV Ruckley. Quality of life follow-
ing lower limb amputation for peripheral arterial disease. European journal of
vascular surgery, 7(4):448–451, 1993.
[117] Jacquelin Perry, Mary Garrett, JoAnne K Gronley, and Sara J Mulroy. Clas-
sification of walking handicap in the stroke population. Stroke, 26(6):982–989,
1995.
[118] Christopher M Powers, Sreesha Rao, and Jacquelin Perry. Knee kinetics in
trans-tibial amputee gait. Gait & posture, 8(1):1–7, 1998.
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